Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2023 Annual Meeting | P11 - Poster Session 11

Wednesday 04/26/23
11:45 AM - 12:45 PM EST Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Neuro-oncology, Aging, Dementia, Cognitive, and Behavioral Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Education, Research, and Methodology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Headache, Infectious Disease, Movement Disorders, Multiple Sclerosis, Neuro Trauma and Critical Care, Neuromuscular and Clinical Neurophysiology (EMG)
0.00 CME credit

Program Materials Program Evaluations

Event Timeline
11:45 AM - 12:45 PM EST Abstract 9-001 - Fenfluramine Treatment Is Associated With Improvement in Everyday Executive Function in Adults With Lennox-Gastaut Syndrome: Post-Hoc Analysis of Dose Effects From a Phase 3 Trial Rationale
Kelly G. Knupp, MD
11:45 AM - 12:45 PM EST Abstract 9-002 - Efficacy of Soticlestat Treatment by Seizure Type in Patients with Dravet Syndrome or Lennox–Gastaut Syndrome in a Phase 2, Randomized, Placebo-controlled Study (ELEKTRA)
Naga Venkatesha Murthy Pathi Jagannatham, MD
11:45 AM - 12:45 PM EST Abstract 9-003 - 12-Month Effectiveness and Tolerability of Brivaracetam in the Real-World: The International EXPERIENCE Pooled Analysis
Herbert Peeples, II, Other
11:45 AM - 12:45 PM EST Abstract 9-004 - Early and Sustained Treatment Effect of Adjunctive Perampanel in Patients with Seizures Associated with Lennox-Gastaut Syndrome (LGS): A Post Hoc Analysis
Stella Leock Ngo, PhD
11:45 AM - 12:45 PM EST Abstract 9-005 - Long-Term Efficacy of Perampanel Monotherapy in Patients with Newly Diagnosed/Currently Untreated Recurrent Focal-Onset Seizures: FREEDOM Study 342 Extension Phase Analysis by Seizure Type
Marcia E. Morita-Sherman, MD
11:45 AM - 12:45 PM EST Abstract 9-006 - Concomitant Drug Load Reduction During Adjunctive Cenobamate Therapy: Post-hoc Analysis of a Phase 3, Open-Label Study
Sami M. Aboumatar, MD
11:45 AM - 12:45 PM EST Abstract 9-007 - Effects of Cenobamate on Weight: Post-hoc Analyses of Global Phase 2 and 3 Studies
Louis Ferrari
11:45 AM - 12:45 PM EST Abstract 9-008 - Perampanel for Treatment of Focal and Generalized Epilepsy in Everyday Clinical Practice: Evidence from PERMIT and PROVE
Stella Leock Ngo, PhD
11:45 AM - 12:45 PM EST Abstract 9-009 - Long-Term Quality of Life in Patients With Focal Seizures Treated With ESL: Pooled Analysis From 3 Phase III Open-Label Extension Studies
David Cantu, PhD
11:45 AM - 12:45 PM EST Abstract 9-010 - Effectiveness and Tolerability of Brivaracetam by Number of Lifetime Antiseizure Medications in Adults with Focal Onset Seizures: Pooled Data From Two Real-world Studies
Mallory Alonso, PharmD
11:45 AM - 12:45 PM EST Abstract 9-011 - ELEVATE Study 410: Assessment of Cognition (EpiTrack®) Following Perampanel (Monotherapy/First Adjunctive) in Patients with Epilepsy and a History of Psychiatric/Behavioral Events
Stella Leock Ngo, PhD
11:45 AM - 12:45 PM EST Abstract 9-012 - A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Evaluate the Safety and Efficacy of XEN1101 as an Adjunctive Therapy in the Treatment of Primary Generalized Tonic-Clonic Seizures
Cynthia L. Harden, MD
11:45 AM - 12:45 PM EST Abstract 15-001 - Assessing Undergraduate Neurology Pipeline Programs: A Systematic Review
Ramisha Aymon, Other
11:45 AM - 12:45 PM EST Abstract 15-002 - Novel BIPOC+ Next-Generation Summer Neuroscience Research Internship Initiative
Ka-Ho Wong
11:45 AM - 12:45 PM EST Abstract 15-003 - An Advocacy Leadership Training in Neurology for High School Students: A Pilot Study
Tyler Alexander Gumpel
11:45 AM - 12:45 PM EST Abstract 15-005 - How to Increase the Neurology Pipeline? A Critical Systematic Review of K-12 Neurology Pipeline Programs
Naomi Sara Lebowitz, Other
11:45 AM - 12:45 PM EST Abstract 15-006 - Preclinical Neuroscience Education: Planting the Seed for a Career in Neurology
Jeremy J. Laukka, PhD
11:45 AM - 12:45 PM EST Abstract 3-001 - Longitudinal Brain Volume Findings in an Outpatient Practice of Young People with MS
Kimberly O'Neill, MD
11:45 AM - 12:45 PM EST Abstract 3-002 - Multifaceted Evaluation of Double Inversion Recovery Brain MRI in Detection of Cervical Spine Multiple Sclerosis Lesions
Shivam Patel
11:45 AM - 12:45 PM EST Abstract 3-003 - Functional and Structural MRI Changes Associated With Cognitive Worsening in Multiple Sclerosis: A 3-Year Longitudinal Study
Paolo Preziosa
11:45 AM - 12:45 PM EST Abstract 3-004 - Early detection of silent brain function changes in multiple sclerosis using magnetoencephalography (MEG): Towards an imaging biomarker
Mouhamad Hammami
11:45 AM - 12:45 PM EST Abstract 3-005 - Quantitative brain 18F-FDG PET/CT analysis in seronegative autoimmune encephalitis
Samantha Roman, MD
11:45 AM - 12:45 PM EST Abstract 3-006 - Deep Learning Reconstruction of Lesion-Free Representations of the Brain in Multiple Sclerosis Patients
Despoina Ioannidou, PhD
11:45 AM - 12:45 PM EST Abstract 3-007 - Neural effects of fatigue on cognition in relapsing multiple sclerosis detected by magnetoencephalography: Towards an imaging biomarker
Anza Memon, MD, FAAN
11:45 AM - 12:45 PM EST Abstract 3-008 - The Challenges of MRI in Clinical Practice
Cortnee Roman, NP
11:45 AM - 12:45 PM EST Abstract 3-009 - Imaging Chronic Active Lesions in Multiple Sclerosis: a Consensus Statement from the North America Imaging in Multiple Sclerosis Cooperative
Francesca Bagnato, MD
11:45 AM - 12:45 PM EST Abstract 3-010 - Predicting MRI Changes in Patients with MS in the Absence of Acute Inflammation
Nolan Campbell
11:45 AM - 12:45 PM EST Abstract 3-011 - Impact of natalizumab on chronic active lesions
Marjo Nylund
11:45 AM - 12:45 PM EST Abstract 3-012 - Association between retinal layer thickness and cortical lesions at the onset of clinically isolated syndrome
Kyriakoula Varmpompiti, MBBS
11:45 AM - 12:45 PM EST Abstract 3-013 - International Consensus on Smoldering Disease in Multiple Sclerosis using the Delphi Method
Francesca Bagnato, MD
11:45 AM - 12:45 PM EST Abstract 3-014 - TMS Targets for Multiple Sclerosis Related Depression Derived Using a Precomputed Functional Connectome
William Drew
11:45 AM - 12:45 PM EST Abstract 3-015 - Exploring New Imaging Biomarkers: 3D Conformational Analysis Of The Medulla And Upper Cervical Spinal Cord In People With Relapsing Multiple Sclerosis
Tatum Moog
11:45 AM - 12:45 PM EST Abstract 3-016 - Overlapping and Distinguishing Features Among MS, NMOSD, MOGAD and Other Atypical Demyelinating Syndromes of the Central Nervous System
Bade Gulec
11:45 AM - 12:45 PM EST Abstract 3-017 - African Americans with multiple sclerosis (MS) are more likely to have paramagnetic rim lesions (PRLs) compared to Caucasians
Nara Michaelson, MD
11:45 AM - 12:45 PM EST Abstract 3-018 - Brain MRI Activity During the Year Before Pregnancy Can Predict Long-Term Clinical Worsening in Patients with Multiple Sclerosis
Omri Zveik
11:45 AM - 12:45 PM EST Abstract 12-001 - Neurologic Implications of Spaceflight
Mark Joshua Rosenberg, MD
11:45 AM - 12:45 PM EST Abstract 12-002 - Infratentorial Superficial Siderosis and Spontaneous Intracranial Hypotension: Type, Time course, and Treatment of underlying Spinal Cerebrospinal Fluid Leak.
Jennifer Harris, MD
11:45 AM - 12:45 PM EST Abstract 12-003 - Orthostatic Hemifacial Spasm, Trigeminal Paresthesias, and Pulsatile Tinnitus in the Setting of Idiopathic Intracranial Hypertension
Madison Michelle Patrick
11:45 AM - 12:45 PM EST Abstract 12-004 - Gauging the pressure: The clinical dilemma with Chiari!
Elelia Phillips
11:45 AM - 12:45 PM EST Abstract 12-006 - A Case of Pantothenate Kinase-Associated Neurodegeneration (PKAN) in a Patient with One Known Pathologic Variant and One Variant of Unknown Significance
Bryn Rubin
11:45 AM - 12:45 PM EST Abstract 12-007 - A Comparison of Phenotypic and Genotypic Features in Identical Twins with Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-like Episodes (MELAS)
Joyce Mbiziwo-Tiapo, MD
11:45 AM - 12:45 PM EST Abstract 6-001 - Optical Coherence Tomography Angiography (OCTA) Retinal Imaging Can Detect Burden of Small Vessel Disease and Amyloid Deposition in the Brain
Camilo Bermudez, MD, PhD
11:45 AM - 12:45 PM EST Abstract 6-002 - Remote Ischemic Conditioning with Novel Optical Sensor Feedback Device in Acute Ischemic Stroke- a feasibility study
Robert Joseph Cruz Sarmiento, MD
11:45 AM - 12:45 PM EST Abstract 6-003 - 3-Dimensional Subcortical Vascular Maps
Sally Ladsaria, MD
11:45 AM - 12:45 PM EST Abstract 6-006 - White matter disease and recovery following endovascular thrombectomy after acute ischemic stroke
Nicholas Vigilante, III
11:45 AM - 12:45 PM EST Abstract 6-007 - Clinical and Radiological Features of Intracerebral Hemorrhage in Pregnant and Postpartum Patients
Mehriban Sariyeva
11:45 AM - 12:45 PM EST Abstract 6-008 - Evaluation of Imaging Techniques for the Measurement of Extracranial Internal Carotid Stenosis: A Systematic Scoping Review.
Marc Lawrence, MD
11:45 AM - 12:45 PM EST Abstract 6-009 - Framingham Risk Score and White Matter Disease Progression
Hossam Youssef
11:45 AM - 12:45 PM EST Abstract 6-010 - Expediting emergent MRI in acute ischemic stroke by extending CT scout image: a simple intervention to decrease time to treatment
Yasmin Aghajan, MD
11:45 AM - 12:45 PM EST Abstract 6-011 - Multi-territorial Acute Ischemic Stroke with low T2* signal—an MRI marker for differentiating infective endocarditis from cancer-related stroke
Akira Machida
11:45 AM - 12:45 PM EST Abstract 6-013 - Penumbra without core in acute hemispheric stroke syndrome: an imaging biomarker for underlying atherosclerotic intracranial stenosis
Gyanendra Kumar, MD, FAAN
11:45 AM - 12:45 PM EST Abstract 6-014 - To Investigate When and What to Do for Deep Subcortical White Matter Hyperintensity (DSWMH) in a Large Cohort Study
Yoshinori Nishimoto
11:45 AM - 12:45 PM EST Abstract 6-015 - A Cross-Sectional Study of Home Blood Pressure Monitoring after Stroke
Melissa Mariscal, MD
11:45 AM - 12:45 PM EST Abstract 6-016 - Identifying optimal cut points of National Institutes of Health Stroke Scale to Predict Mortality: A Population-based Assessment
Robert Stanton, II, MD
11:45 AM - 12:45 PM EST Abstract 6-017 - Ischemic Changes in Carotid Endarterectomies are More Severe in Left-Sided Procedures
Amir Mina
11:45 AM - 12:45 PM EST Abstract 6-018 - Diagnosis and Prognosis of Stroke Using Artificial Intelligence and Imaging
Kathleen Miao
11:45 AM - 12:45 PM EST Abstract 6-019 - Stroke and Transient Ischemic Attack Care Transitions Clinic: Providing Timely, Evidence-Based Care
Shivani Daryani, PA
11:45 AM - 12:45 PM EST Abstract 6-020 - A Systematic Review on the Duration of Antipsychotic Exposure and the Risk of Cerebrovascular Events in Elderly Patients
Gregory Peter Devine
11:45 AM - 12:45 PM EST Abstract 6-021 - Very early neurological deterioration after thrombolysis
Ying-Chi Sandy Shen, MD
11:45 AM - 12:45 PM EST Abstract 6-022 - Distinct lesion features and underlying mechanisms in patients with acute multiple infarcts in multiple cerebral circulations
Yuhui Sha
11:45 AM - 12:45 PM EST Abstract 6-023 - Stroke Etiology of Large Vessel Occlusion Acute Ischemic Stroke (LVO-AIS) In a Racially Diverse Young Adult Cohort Using ASCOD Classification
Jonathan William Handshoe, MD
11:45 AM - 12:45 PM EST Abstract 6-024 - Multidisciplinary approach to Patent Foramen Ovale (PFO) closure for Cryptogenic Stroke: Brain-Heart Board Experience
Muhib Khan, MD, FAAN
11:45 AM - 12:45 PM EST Abstract 6-025 - Vascular risk factors, cerebral collateral efficiency and burden of small vessel disease in anterior circulation large vessel occlusion stroke
Nadia McMillan, MD, PhD
11:45 AM - 12:45 PM EST Abstract 6-026 - Case Series of Apixaban Failure in Active Cancer Patients
Muhammad Ismail Khalid Yousaf, MD
11:45 AM - 12:45 PM EST Abstract 6-027 - LACE+ is marginally predictive of 30-day readmission after stroke
Muhib Khan, MD, FAAN
11:45 AM - 12:45 PM EST Abstract 6-028 - Clinical Review 32 Cases of Medullary Infarction from a Tertiary Center
Prasanna Venkatesan Eswaradass, MD
11:45 AM - 12:45 PM EST Abstract 6-030 - Association of Co-morbidities with Functional Outcomes in Stroke Patients with Atrial Fibrillation on long-term Oral anticoagulation
Mohammad Abdurrehman Sheikh, MBBS
11:45 AM - 12:45 PM EST Abstract 6-031 - Quality of Life and Emotional Health of Stroke Survivors and Caregiver After Stroke Camp
Dhara Mehta, DO
11:45 AM - 12:45 PM EST Abstract 6-032 - Diagnostic Yield of Extended Cardiac Patch Monitoring in Cryptogenic Stroke Patients
Victoria Michelle Rice, DO
11:45 AM - 12:45 PM EST Abstract 7-001 - Stepwise functional brain architecture from disease epicenter correlates with atrophy in progressive supranuclear palsy
Edoardo G. Spinelli, MD
11:45 AM - 12:45 PM EST Abstract 7-002 - Volumetric Analysis of Hippocampal Subregions and Subfields in Left and Right Predominant Semantic Dementia
Arenn Faye Carlos, MD
11:45 AM - 12:45 PM EST Abstract 7-003 - Characterization of FTLD spectrum through advanced diffusion-weighted MRI metrics: a connectome approach
Edoardo G. Spinelli, MD
11:45 AM - 12:45 PM EST Abstract 7-004 - 123I-Ioflupane SPECT Striatal Binding Ratio Predicts Progression of Parkinsonism in a Dementia with Lewy Bodies Cohort
Emily Maly, MD
11:45 AM - 12:45 PM EST Abstract 7-005 - Early detection of mild cognitive impairment (MCI) using MEG
Mouhamad Hammami
11:45 AM - 12:45 PM EST Abstract 7-006 - APOE e4 Influences Within and Between Network Functional Connectivity in Atypical Alzheimer Disease
Neha Atulkumar Singh, PhD
11:45 AM - 12:45 PM EST Abstract 7-007 - Periventricular White Matter Fractional Anisotropy as a Biomarker of Cerebral Small Vessel Disease
Banafsheh Shakibajahromi, MD
11:45 AM - 12:45 PM EST Abstract 7-008 - Age - related vulnerability of the human brain connectome
Edoardo G. Spinelli, MD
11:45 AM - 12:45 PM EST Abstract 7-009 - Effect of Amyloid PET on Clinical Management of Alzheimer's Disease Medication Therapy: The Khatib Study
Taylor Ariko
11:45 AM - 12:45 PM EST Abstract 1-001 - Validation of a Non-Invasive Method Using Mechanical Extensometer for the Estimation of Intracranial Compliance Using Repeated Measures Agreement Analysis
Hayley Gibler Williams, MD
11:45 AM - 12:45 PM EST Abstract 1-002 - Hypertonic Saline Solution versus Mannitol in Children with Intracranial Hypertension: A Systematic Review and Meta-Analysis
Artur Menegaz de Almeida
11:45 AM - 12:45 PM EST Abstract 1-003 - Functional near-infrared spectroscopy as a tool to assess residual and covert consciousness in the intensive care unit
Karnig Kazazian
11:45 AM - 12:45 PM EST Abstract 1-004 - The Use of Standardized Interpretation & Reporting for Multimodality Neuromonitoring
Rudy Luna, MD
11:45 AM - 12:45 PM EST Abstract 1-005 - Quantitative Pupillometry is Not Impacted By IV Opioid or Sedative Bolus Dosing
Joshua Battley, MD
11:45 AM - 12:45 PM EST Abstract 1-006 - Quantitative Pupillometry in Patients with Surgical Decompression
Ciara Hupp, MD
11:45 AM - 12:45 PM EST Abstract 10-001 - Sural Nerve Biopsy Assessment by Individual Histologic Preparations: An Observational Cohort Study of 100 Consecutive Cases
Pannathat Soontrapa, MD
11:45 AM - 12:45 PM EST Abstract 10-002 - Multiparametric Quantitative MRI of Peripheral Nerves to Differentiate Axonal from Demyelinating Neuropathies
Yongsheng Chen, PhD
11:45 AM - 12:45 PM EST Abstract 10-003 - Genotypic And Phenotypic Features of Patients with GJB1 Mutations: Single Center Experience
Fatma Yesim Parman, MD
11:45 AM - 12:45 PM EST Abstract 10-004 - Neuropathy as an adverse effect of proteasomal inhibitors in multiple myeloma treatment: a network meta-analysis
Anisha Garg, MD
11:45 AM - 12:45 PM EST Abstract 10-005 - Peripheral Nerve Pathology in Antibody Positive Paraneoplastic Neurological Syndromes
Andre Granger, MD, MBA
11:45 AM - 12:45 PM EST Abstract 10-006 - Novel Biomarker for Demyelination in Diabetic Distal Symmetric Polyneuropathy: A Prospective Study
Kazim Jaffry
11:45 AM - 12:45 PM EST Abstract 10-007 - Characteristics of Carpal Tunnel Syndrome in Wild-Type Transthyretin Amyloidosis
Angela C. Russell, MD
11:45 AM - 12:45 PM EST Abstract 10-009 - Single Center Experience of RETREG1-related Hereditary Sensory Autonomic Neuropathy in Turkey
Arman Cakar
11:45 AM - 12:45 PM EST Abstract 10-010 - Clinical features and real-world outcomes of Guillain–Barré syndrome in the Philippines
Adrian Isidoro Espiritu, MD
11:45 AM - 12:45 PM EST Abstract 10-011 - Motor Nerve Conduction Slowing in Diabetic Distal Symmetrical Polyneuropathy: A Novel Approach
Mustafa Jaffry
11:45 AM - 12:45 PM EST Abstract 10-012 - Kappa Light Chain Deposition Disease Presenting with Axonal Sensorimotor Polyneuropathy in the Absence of Clinically Significant Renal Pathology
Nadia Khalil, MD
11:45 AM - 12:45 PM EST Abstract 10-013 - Clinical Implications of Specific Autoantibodies in Chronic Inflammatory Neuropathies
Victor Bushlyar, MD
11:45 AM - 12:45 PM EST Abstract 10-014 - Expanded Reference Tissue Methylome for Tissue-of-origin Deconvolution of Cell-free DNA in Plasma from ALS Patients
Mai Yamakawa, MD
11:45 AM - 12:45 PM EST Abstract 10-015 - Presence of deep tendon reflexes may not exclude a diagnosis of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
James Strathdee, MBBS
11:45 AM - 12:45 PM EST Abstract 4-001 - Implementation of Depression Screening and Interventions Protocol in a Pediatric Neurology Residents’ Continuity Clinic: A Quality Improvement Project
Purva Choudhari, MD
11:45 AM - 12:45 PM EST Abstract 4-003 - Social Behavioral Impairments in SYNGAP1-related Intellectual Disability
Hajera Naveed
11:45 AM - 12:45 PM EST Abstract 4-004 - A Cross-Sectional Study of the Neuropsychiatric Phenotype of CACNA1C-Related Disorder
Rebecca Jeannette Levy, MD
11:45 AM - 12:45 PM EST Abstract 4-005 - Sandman Send Me a Dream: Case of Non-24-Hour Sleep-Wake Disorder in a Sighted Pediatric Patient
Matthew Hart, MD
11:45 AM - 12:45 PM EST Abstract 4-006 - Acute psychosis as initial presentation for Neurofibromatosis Type 2
Jason Singh Gill, MD, PhD
11:45 AM - 12:45 PM EST Abstract 4-007 - Adding Tools to Our Toolkit: How to Care for Children with Autism and Challenging Behaviors
Christina Massrey, MD
11:45 AM - 12:45 PM EST Abstract 4-008 - Mitochondrial Complex I Deficiency Associated with Biallelic NDUFA13 Variants Lead to Leigh Syndrome
Rauan Kaiyrzhanov, MD
11:45 AM - 12:45 PM EST Abstract 4-009 - Scurvy presenting with difficulties to walk and weakness in pediatric patients; 2 case reports.
Anastasia Railean, MD
11:45 AM - 12:45 PM EST Abstract 4-010 - “Confounding Contractures” A Non-Lethal Presentation of a Lethal Disorder
Gerard Mullane
11:45 AM - 12:45 PM EST Abstract 4-011 - Large-Cohort Characterization of Pediatric Small Fiber Neuropathy
Alexander James Mills
11:45 AM - 12:45 PM EST Abstract 4-012 - Disease Impact and Burden in Patients with SCN2A-Related Developmental and Epileptic Encephalopathy
Brian Pfister
11:45 AM - 12:45 PM EST Abstract 13-001 - Rapid Reversal of Locked-in Syndrome from Acute Neuroinvasive West Nile Virus with High-dose Steroids
Sumayya Mohammed, MD
11:45 AM - 12:45 PM EST Abstract 13-002 - A Case of Monkeypox-associated Encephalomyelitis—Colorado, July–August, 2022
Kelli Money, MD, PhD
11:45 AM - 12:45 PM EST Abstract 13-003 - Neurological Manifestations of Human Monkeypox: A Systematic Review
Bahadar Singh Srichawla, DO, MS
11:45 AM - 12:45 PM EST Abstract 13-004 - Neuroinvasive Manifestations of West Nile Virus Infection: Lumbar Polyneuropathy, Chorioretinal Lesions, Sensorineural Hearing Loss
Matthew William Flounders, DO
11:45 AM - 12:45 PM EST Abstract 13-005 - Persistent CMV in Brain Tissue of a Patient with Congenital CMV Following Resolution of Viremia
Jeffrey Kuerbitz, PhD
11:45 AM - 12:45 PM EST Abstract 13-006 - HHV-7 Encephalitis: The Rare Infection and Its Outcome on a Child
Ítalo Barros Andrade
11:45 AM - 12:45 PM EST Abstract 5-001 - Deep Brain Stimulation of the Subthalamic Nucleus in a Patient With X-Linked Dystonia-Parkinsonism.
Sviatoslav Redko, MD
11:45 AM - 12:45 PM EST Abstract 5-002 - Improvement in Cervical Dystonia – Outcomes of a Prospective, Multicenter, International Registry of Deep Brain Stimulation (DBS)
Alberto Albanese, MD
11:45 AM - 12:45 PM EST Abstract 5-003 - Long-term Safety of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia in Phase 3, Open-label, Multicenter ASPEN-OLS Trial
Todd Gross
11:45 AM - 12:45 PM EST Abstract 5-004 - Dystonia is Associated with Macro and Microstructural Abnormalities of the Cerebellum: Analysis of Volumetric and Diffusion-Weighted MRI Data in the UK Biobank.
Xenos Mason, MD
11:45 AM - 12:45 PM EST Abstract 5-005 - Clinical and Pathological Characterization of VPS16 Dystonia
Mariel Yvonne Pullman, MD
11:45 AM - 12:45 PM EST Abstract 5-006 - Efficacy and Safety of DaxibotulinumtoxinA for Injection Over Successive Treatments in Adults With Cervical Dystonia in the Phase 3 ASPEN-1 and ASPEN-OLS Trials
Todd Gross
11:45 AM - 12:45 PM EST Abstract 5-008 - Dystonia with myoclonus and vertical supranuclear gaze palsy associated with a rare GNB1 variant
Nikolai Gil Diwa Reyes, MD
11:45 AM - 12:45 PM EST Abstract 5-009 - Wearable device to measure disease severity in cervical dystonia
Shameer Rafee, MBBS
11:45 AM - 12:45 PM EST Abstract 5-010 - Global Improvements and Psychiatric Stability in Adults with Tardive Dyskinesia: Post Hoc Analyses of Two Long-Term Valbenazine Studies
Olga Klepitskaya, MD, FAAN
11:45 AM - 12:45 PM EST Abstract 5-011 - Symptom severity, impairment and health outcomes in patients with Functional Tic Like Behaviours
Lindsay Berg, Other
11:45 AM - 12:45 PM EST Abstract 5-012 - Sustained Treatment Response with Long-Term Valbenazine in Patients with Tardive Dyskinesia
Eric Jen
11:45 AM - 12:45 PM EST Abstract 5-013 - The Association Between Gender Minority Identity and Functional Tic-Like Behaviors During the COVID-19 Pandemic
Davide Martino, MD, PhD
11:45 AM - 12:45 PM EST Abstract 5-014 - Characterizing Functional Tics
Anh-Tho Antoinette Thi Nguyen
11:45 AM - 12:45 PM EST Abstract 5-015 - Etiological factors associated with functional tic-like behaviours during the COVID-19 pandemic
Lindsay Berg, Other
11:45 AM - 12:45 PM EST Abstract 5-016 - Black and Hispanic Individuals with Tourette Syndrome are Under-Represented in Specialty Clinics
Marisela E. Dy-Hollins, MD, MSCR, FAAN
11:45 AM - 12:45 PM EST Abstract 2-001 - A Cross-Sectional Survey of Prevailing Opinions from Headache Specialists Regarding Status Migrainosus Management
Jennifer Victoria Robblee, MD
11:45 AM - 12:45 PM EST Abstract 2-002 - Botulinum Toxin Off Label Use in Chronic Migraine Patients: An American Headache Society Clinical Survey Study
Ashhar Ali, DO, FAAN
11:45 AM - 12:45 PM EST Abstract 2-003 - Clinical features and ICHD headache diagnoses for patients with prominent craniofacial pain referred by a rhinologist to headache specialists
Odei Alayyas, MD
11:45 AM - 12:45 PM EST Abstract 2-004 - Positive Establishment of a Digital Working Alliance with a Prescription Digital Therapeutic in Patients with Migraine
Shaheen E. Lakhan, MD, PhD, MEd, FAAN
11:45 AM - 12:45 PM EST Abstract 2-005 - Cervical Dystonia in a Headache Population: General Medical Education (GME) Training to Standardize Screening
Ryoichi Inoue, MD
11:45 AM - 12:45 PM EST Abstract 2-006 - Real-world Treatment Combinations of Migraine-specific Prescription Medications
Ali Mohajer, PhD
11:45 AM - 12:45 PM EST Abstract 2-007 - ZAPTed (Zygomatic Arch and Point Triggers) Protocol for Botulinum Toxin Injections in the Management of Refractory Trigeminal Neuralgia
Arun Aggarwal, FRACP
11:45 AM - 12:45 PM EST Abstract 2-008 - Continuous Ketamine Infusion for Treatment of Refractory Headache in the Inpatient Setting
Byoungchul Kim, MD
11:45 AM - 12:45 PM EST Abstract 2-009 - A History of Abuse is Associated with More Severe Migraine- and Pain-Related Disability: Results from the American Registry of Migraine Research (ARMR)
Meesha Trivedi
11:45 AM - 12:45 PM EST Abstract 2-010 - Prevalence and risk factors of primary headache disorders among Healthcare professionals in México, results of a multicenter survey
Rodolfo Manuel Roman Guzman, Sr., MD
11:45 AM - 12:45 PM EST Abstract 2-012 - Headache in acute ischemic stroke. Results from two Mexican databases.
Alejandro R. Marfil-Rivera, MD
11:45 AM - 12:45 PM EST Abstract 11-001 - Low-dose radiation followed by on-target inhibition of Galectin-3 in combination with anti-4-1BB monoclonal antibody regulates immune responses in Group 3 and Group 4 medulloblastoma mouse model
David Cachia, MD
11:45 AM - 12:45 PM EST Abstract 11-002 - Cell Lineage and Pseudotime Inference for Single-cell Transcriptomics Analysis of Chemoresistance in GBM
Isabelle Charlotte Preddy
11:45 AM - 12:45 PM EST Abstract 11-003 - Patient-Derived Organoids Recapitulate Intrinsic Immune Landscapes and Progenitor Populations of Glioblastoma.
Fumihiro Watanabe, PhD
11:45 AM - 12:45 PM EST Abstract 11-004 - Modeling of Aryl Hydrocarbon Receptor Pathway Intrinsic Immunometabolic Role using Glioblastoma Stem Cells and Patient-Derived Organoids
Fumihiro Watanabe, PhD
11:45 AM - 12:45 PM EST Abstract 11-005 - Co-targeting CK1ε and PIK3CB/p110ß as a Therapeutic Approach for Glioblastoma.
Eileen Xu
Faculty Disclosures
Douglas L. Arnold, MD, FAAN Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Celgene. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Frequency Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xfacto communications. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Arnold has stock in NeuroRx.
Elinor Ben-Menachem, MD, FAAN Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arvelle. Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharma. Dr. Ben-Menachem has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Acta Neurologica Scandinvica. The institution of Dr. Ben-Menachem has received research support from zogenic.
Susan B. Bressman, MD, FAAN The institution of Dr. Bressman has received research support from Michael J Fox Foundation . The institution of Dr. Bressman has received research support from NIH .
Thomas G. Brott, MD, FAAN Dr. Brott has nothing to disclose.
Cynthia L. Comella, MD, FAAN Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acorda Therapeutics. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck LTD. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan Inc. Dr. Comella has received personal compensation in the range of $0-$499 for serving as a Consultant for Merz. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Comella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion. Dr. Comella has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Aeon. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz . Dr. Comella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceutical. Dr. Comella has received publishing royalties from a publication relating to health care. Dr. Comella has received publishing royalties from a publication relating to health care.
Kathleen B. Digre, MD, FAAN Dr. Digre has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Headache Society. The institution of Dr. Digre has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuro-ophthalmology. The institution of Dr. Digre has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Utah Womens Health Review. Dr. Digre has received intellectual property interests from a discovery or technology relating to health care. Dr. Digre has received intellectual property interests from a discovery or technology relating to health care. Dr. Digre has received intellectual property interests from a discovery or technology relating to health care. Dr. Digre has received publishing royalties from a publication relating to health care. Dr. Digre has received publishing royalties from a publication relating to health care.
Peter J. Dyck, MD,FAAN Dr. Dyck has nothing to disclose.
R Edward Faught, Jr., MD, FAAN Dr. Faught has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Azurity. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gideon, Essary, Tardio and Carter PLC, Nashville TN TN law firm. Dr. Faught has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Friedman Dazio and Zulanas Law Firm Birmingham AL. The institution of Dr. Faught has received research support from UCB Pharma.
Matthew E. Fink, MD, FAAN Dr. Fink has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Relias LLC.
John F. Foley, MD, FAAN The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave. Dr. Foley has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics . The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Foley has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Foley has stock in InterPRO Bioscience. The institution of Dr. Foley has received research support from Biogen. The institution of Dr. Foley has received research support from Novartis. The institution of Dr. Foley has received research support from Octave. The institution of Dr. Foley has received research support from Genentech. The institution of Dr. Foley has received research support from Imstem. The institution of Dr. Foley has received research support from Aegir.
Cynthia L. Harden, MD Dr. Harden has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Dr. Harden has stock in Xenon Pharmaceuticals Inc.. Dr. Harden has received intellectual property interests from a discovery or technology relating to health care.
Roger E. Kelley, Jr., MD, FAAN Dr. Kelley has nothing to disclose.
David S. Knopman, MD, FAAN Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
Lauren B. Krupp, MD, FAAN Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lerhman. Dr. Krupp has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for medscape. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroLive. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Krupp has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Cleveland Clinic. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for MCIC. The institution of Dr. Krupp has received research support from Biogen. The institution of Dr. Krupp has received research support from National Multiple Sclerosis Society. Dr. Krupp has received intellectual property interests from a discovery or technology relating to health care.
Anthony E. Lang, MD, FAAN Dr. Lang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie, Acorda, AFFiRis, Biogen, Denali, Janssen, Intracellular, Kallyope, Lundbeck, Paladin, Retrophin, Roche, Sun Pharma, Theravance, and Corticobasal Degeneration Solutions, Sun Pharma, Medichem, Medtronic, AbbVie and Sunovion. The institution of Dr. Lang has received research support from AbbVie. Dr. Lang has received publishing royalties from a publication relating to health care.
Dana Leifer, MD, FAAN Dr. Leifer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Leifer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Network. Dr. Leifer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atheneum Partners. Dr. Leifer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Agilence. Dr. Leifer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Protembis. Dr. Leifer has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Spigarelli Law Firm. Dr. Leifer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Anzalone Law Firm. Dr. Leifer has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Finz & Finz. Dr. Leifer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for WIT Legal. Dr. Leifer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for DOAR. Dr. Leifer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Pirotti &Glaat. Dr. Leifer has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Brown& Barron. Dr. Leifer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Morris Williams. Dr. Leifer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Meyers Evans. Dr. Leifer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Mandell & Schwartz. Dr. Leifer has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Golomb & Honik. Dr. Leifer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Silver Glob & Teitell. Dr. Leifer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Abramson Brown Dugan. Dr. Leifer has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Cochran Law Firm. Dr. Leifer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Hackensack Meridian Health. Dr. Leifer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for KAMMCO. Dr. Leifer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Kennedy Johnson. Dr. Leifer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Philips Parker. Dr. Leifer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Schochet . Dr. Leifer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Walsh Woodard. Dr. Leifer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Wicker Smith. Dr. Leifer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Yoeli Gottlieb. Dr. Leifer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Steven Friedman. Dr. Leifer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Wilson Elser. Dr. Leifer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Ross Feller Casey. Dr. Leifer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gentile & Associates. Dr. Leifer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Dansker and Aspromonte. Dr. Leifer has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Norman Steiner, Esq.. Dr. Leifer has stock in Landsdowne Labs. Dr. Leifer has stock in Neurotechnology Investors . The institution of Dr. Leifer has received research support from NIH.
James B. Leverenz, MD, FAAN Dr. Leverenz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Leverenz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Leverenz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai.
Walter J. Molofsky, MD Dr. Molofsky has nothing to disclose.
Nancy M. Nealon, MD Dr. Nealon has nothing to disclose.
Ronald C. Petersen, PhD, MD, FAAN Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nestle. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech, Inc.. Dr. Petersen has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche, Inc.. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
Stefan M. Pulst, MD, FAAN Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for venrock. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Leverna. Dr. Pulst has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Leninthal LLC. The institution of Dr. Pulst has received research support from NINDS. Dr. Pulst has received intellectual property interests from a discovery or technology relating to health care.
John W. Rose, MD, FAAN The institution of Dr. Rose has received research support from National Multiple Sclerosis Society. The institution of Dr. Rose has received research support from Guthy Jackson Charitable Foundation. The institution of Dr. Rose has received research support from NIH . The institution of Dr. Rose has received research support from VA. The institution of Dr. Rose has received research support from Biogen. The institution of Dr. Rose has received research support from Friends of MS. Dr. Rose has received intellectual property interests from a discovery or technology relating to health care.
William E. Rosenfeld, MD, FAAN The institution of Dr. Rosenfeld has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for SK Life Science. Dr. Rosenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for SK Life Science.
Ashfaq Shuaib, MD Dr. Shuaib has nothing to disclose.
Vincenzo Silani, MD, FAAN Dr. Silani has nothing to disclose.
Carlos Singer, MD Dr. Singer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving as a Video Panel with CNS Ratings LLC. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Course Organiztion with Omniprex Scientific Medical Eduaction. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with Health Monitor Network. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Movement Disorders Society. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Workshop Moderator with International Neurotoxin Association Inc. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Lecturer with CME Outfitteres LLC.
Kenneth L. Tyler, MD, FAAN Dr. Tyler has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Protagonist Therapeutics, Newark CA. Dr. Tyler has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Neurological Association/Wiley. Dr. Tyler has received intellectual property interests from a discovery or technology relating to health care. Dr. Tyler has received publishing royalties from a publication relating to health care. Dr. Tyler has a non-compensated relationship as a Director (ex officio) with American Neurological association that is relevant to AAN interests or activities. Dr. Tyler has a non-compensated relationship as a Director with International Society for Neurovirology that is relevant to AAN interests or activities.
David G. Vossler, MD, FAAN Dr. Vossler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex Pharmaceuticals. Dr. Vossler has received personal compensation in the range of $0-$499 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Vossler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Longboard Pharmaceuticals. Dr. Vossler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon Pharmaceuticals. Dr. Vossler has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Life Science. The institution of Dr. Vossler has received research support from SK Life Science. The institution of Dr. Vossler has received research support from Xenon Pharmaceuticals. The institution of Dr. Vossler has received research support from Longboard Pharmaceuticals.
Gregory S. Connor, MD The institution of Dr. Connor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SK Life Sciences. The institution of Dr. Connor has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for SK Life Sciences.
Pavel Klein, MD, FAAN The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aquestive. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Sience. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alliance. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvelle Therapeutics. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Aquestive. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion. Dr. Klein has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for PrevEp. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Fenwick . Dr. Klein has received research support from DOD/CURE.
Richard Libman, MD, FAAN Dr. Libman has nothing to disclose.
Anna Czlonkowska, MD Dr. Czlonkowska has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Alexion.
Anne Louise Oaklander, MD,PhD, FAAN The institution of Dr. Oaklander has received research support from National Institutes of Health.
Alberto B. Vasquez, MD No disclosure on file
Howard W. Sander, MD, FAAN Dr. Sander has received personal compensation for serving as an employee of Grifols. Dr. Sander has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Law firm.
Randolph S. Marshall, MD, FAAN The institution of Dr. Marshall has received research support from NIH. Dr. Marshall has received publishing royalties from a publication relating to health care.
Joseph P. Hanna, MD Dr. Hanna has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MCG part of Hearst Health Network. Dr. Hanna has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Attorney General State of Ohio.
Jeff M. Bronstein, MD, PhD Dr. Bronstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ultragenyx. The institution of Dr. Bronstein has received research support from NIH. The institution of Dr. Bronstein has received research support from Levine Foundation.
Rohit Bakshi, MD, FAAN Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. The institution of Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuroimaging. An immediate family member of Dr. Bakshi has received stock or an ownership interest from Biogen. The institution of Dr. Bakshi has received research support from BMS/Celgene. The institution of Dr. Bakshi has received research support from EMD Serono.
Ildefonso Rodriguez-Leyva, MD, PhD, FAAN Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Laboratorios Carnot. Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lilly Eli and Company. Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Torrent Pharmaceuticals Mexico. Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for abbvie allergan.
Alberto Albanese, MD Dr. Albanese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen pharma. Dr. Albanese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merz pharms. Dr. Albanese has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Publishing Group. Dr. Albanese has a non-compensated relationship as a President with International Association on Parkinsonism and Related Disorders that is relevant to AAN interests or activities.
John A. Detre, MD Dr. Detre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hura Imaging. The institution of Dr. Detre has received research support from NIH. Dr. Detre has received personal compensation in the range of $500-$4,999 for serving as a grant proposal reviewer with NIH, VA, European Science Foundation,Deutsche Forschungsgemeinschaft.
Peter A. Calabresi, MD, FAAN Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. An immediate family member of Dr. Calabresi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MyMD. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Myelin Repair Foundation. The institution of Dr. Calabresi has received research support from Genentech. Dr. Calabresi has received publishing royalties from a publication relating to health care. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Grant reveiwer with Myelin Repair Foundation. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker for CME with NYAS. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Academic CME.
Richard L. Barbano, MD, PhD, FAAN Dr. Barbano has received personal compensation for serving as an employee of State of New York/Office of Mental Health. Dr. Barbano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie/Allergan. Dr. Barbano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Oscine. Dr. Barbano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Barbano has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Barbano has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Visual Dx. Dr. Barbano has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for R L Barbano, MD,PhD, PLLC. The institution of Dr. Barbano has received research support from Fox Foundation. The institution of Dr. Barbano has received research support from Revance. The institution of Dr. Barbano has received research support from Vaccinex. The institution of Dr. Barbano has received research support from Dystonia Study Coalition. The institution of Dr. Barbano has received research support from Acadia. Dr. Barbano has received intellectual property interests from a discovery or technology relating to health care.
Sebastian F. Ameriso, MD Dr. Ameriso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PHRI. Dr. Ameriso has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bayer, Boehringer, Abbott, AstraZeneca.
Bruce J E Day, MB,BS,F No disclosure on file
Antonio Gil-Nagel, MD Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EISAI . Dr. Gil-Nagel has received personal compensation in the range of $0-$499 for serving as a Consultant for GW Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Angelini Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoke . Dr. Gil-Nagel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zogenix . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Angelini Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIAL . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EISAI . Dr. Gil-Nagel has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for GW Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PTC Therapeutics . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zogenix . The institution of Dr. Gil-Nagel has received research support from Jazz Pharmaceuticals. The institution of Dr. Gil-Nagel has received research support from PTC Therapeutics. The institution of Dr. Gil-Nagel has received research support from Zogenix. The institution of Dr. Gil-Nagel has received research support from Agencia Estatal Innovacion.
Aksel Siva, MD Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abdi Ibrahim Ilac - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono . The institution of Dr. Siva has received research support from Turkish MS Society. The institution of Dr. Siva has received research support from The Scientific and Technological Research Council Of Turkey - Health Sciences Research Grants.
Ildebrando H. Appollonio, MD Dr. Appollonio has nothing to disclose.
Sheena K. Aurora, MD Dr. Aurora has received personal compensation for serving as an employee of Impel Neuropharma. Dr. Aurora has stock in Impel Neurpharma.
Virgilio Gerald H. Evidente, MD, FAAN Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal. Dr. Evidente has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Evidente has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Ipsen. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. The institution of Dr. Evidente has received research support from Neuraly. The institution of Dr. Evidente has received research support from Revance. The institution of Dr. Evidente has received research support from CND. The institution of Dr. Evidente has received research support from Lundbeck. The institution of Dr. Evidente has received research support from Abbvie. The institution of Dr. Evidente has received research support from Acadia. The institution of Dr. Evidente has received research support from Aptinyx. The institution of Dr. Evidente has received research support from Aeon. The institution of Dr. Evidente has received research support from Bukwang Pharmaceuticals. The institution of Dr. Evidente has received research support from Jazz Pharmaceuticals. The institution of Dr. Evidente has received research support from Scion Neurostim. The institution of Dr. Evidente has received research support from Theravance Biopharma.
Peter J. McAllister, MD, FAAN Dr. McAllister has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aeon. Dr. McAllister has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for lilly. Dr. McAllister has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for teva. Dr. McAllister has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for abbvie. Dr. McAllister has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for biohaven. Dr. McAllister has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for lundbeck. Dr. McAllister has stock in Percept.
Mark Faragher, MBBS, FRACP Dr. Faragher has stock in Argo P/L. Dr. Faragher has stock in Australian Foundation P/L. Dr. Faragher has stock in Argo Infrastructure P/L.
Imad M. Najm, MD Dr. Najm has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai Inc. Dr. Najm has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Inc. Dr. Najm has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai Inc.
Peter Hedera, MD Dr. Hedera has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Hedera has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Hedera has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for University of Louisville.
P. James B. Dyck, MD, FAAN Dr. Dyck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea/Ionis.
Walter N. Kernan, MD Dr. Kernan has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for various law firms.
Alejandro R. Marfil-Rivera, MD Dr. Marfil-Rivera has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Marfil-Rivera has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for lilly.
Alan Z. Segal, MD, FAAN Dr. Segal has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Various Law Firms. Dr. Segal has received publishing royalties from a publication relating to health care.
James F. Meschia, MD, FAAN The institution of Dr. Meschia has received research support from NINDS. The institution of Dr. Meschia has received research support from NINDS.
Jonathan C. Edwards, MD Dr. Edwards has received intellectual property interests from a discovery or technology relating to health care.
Sami M. Aboumatar, MD Dr. Aboumatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Aboumatar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Aboumatar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion.
James E. Galvin, MD, MPH No disclosure on file
Nancy L. Sicotte, MD, FAAN The institution of Dr. Sicotte has received research support from PCORI. The institution of Dr. Sicotte has received research support from NIH. The institution of Dr. Sicotte has received research support from NMSS. Dr. Sicotte has a non-compensated relationship as a National Medical Advisory Committee Chair with National MS Society that is relevant to AAN interests or activities.
Rachel J. Saunders-Pullman, MD The institution of Dr. Saunders-Pullman has received research support from NIH, Bigglesworth Family Foundation, Empire Clinical Research Investigatory Program.
Massimo Filippi, MD, FAAN Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi;. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi- Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Xavier Montalban, MD, PhD, FAAN The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen. The institution of Dr. Montalban has received research support from BMS/ Celgene.
W. Curt LaFrance, Jr., MD, MPH, FAAN Dr. LaFrance has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for medico-legal work.. The institution of Dr. LaFrance has received research support from Department of Defense. Dr. LaFrance has received publishing royalties from a publication relating to health care. Dr. LaFrance has received publishing royalties from a publication relating to health care.
H. A. Jinnah, MD, PhD, FAAN Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takaha/Ene. Dr. Jinnah has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. The institution of Dr. Jinnah has received research support from Addex. The institution of Dr. Jinnah has received research support from Aeon. The institution of Dr. Jinnah has received research support from Revance. The institution of Dr. Jinnah has received research support from Jazz.
Dennis J. Dlugos, MD Dr. Dlugos has received research support from NIH. The institution of Dr. Dlugos has received research support from The Epilepsy Study Consortium.
Anthony Traboulsee, MD Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Traboulsee has received research support from Roche. The institution of Dr. Traboulsee has received research support from Genzyme.
David A. Wolk, MD, FAAN Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuronix. Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Functional Neuromodulation. Dr. Wolk has received personal compensation in the range of $5,000-$9,999 for serving as a CME Speaker with MJH Life Sciences.
Daniel Woo, MD, FAAN Dr. Woo has nothing to disclose.
Aneesh B. Singhal, MD, FAAN An immediate family member of Dr. Singhal has received personal compensation for serving as an employee of Biogen. Dr. Singhal has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Medicolegal Firms. Dr. Singhal has received research support from NIH-NINDS. Dr. Singhal has received publishing royalties from a publication relating to health care. Dr. Singhal has received publishing royalties from a publication relating to health care. Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving as a Honorarium (Education) with Biogen.
Amir Manzoor Arain, MD, FAAN Dr. Arain has nothing to disclose.
Tanuja Chitnis, MD, FAAN Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Siemens. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Academic CME. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche.
Jun Li, MD, PhD, FAAN Dr. Li has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Guidepoint. The institution of Dr. Li has received research support from NIH. Dr. Li has a non-compensated relationship as a Board of Directors with ANA that is relevant to AAN interests or activities.
David J. Nicholl, FRCP, PhD Dr. Nicholl has nothing to disclose.
Gavin Giovannoni, MD Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck KGaA. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Japanese Tobacco. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aurinia Pharmaceuticals. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Oxford Health Policy Forum. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Peervoice. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Bristows .
William Rooney, PhD Dr. Rooney has nothing to disclose.
Roberto P. Ortega, MD No disclosure on file
Brett M. Kissela, MD, FAAN, MS The institution of Dr. Kissela has received research support from NIH/NINDS and NCATS.
Winona Tse, MD Dr. Tse has nothing to disclose.
Jerzy P. Szaflarski, MD, PhD, FAAN Dr. Szaflarski has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Szaflarski has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LivaNova Inc. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gidley, Sarli & Marusak, LLP. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firm. Dr. Szaflarski has stock in AdCel Biopharma, LLC. Dr. Szaflarski has stock in iFovea.
Nutan Sharma, MD, PhD, FAAN Dr. Sharma has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. Dr. Sharma has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. Dr. Sharma has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Cambridge Expert Witness. The institution of Dr. Sharma has received research support from NIH.
Christopher J. Klein, MD, FAAN Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo Therapeutics . Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Faze Medicine .
Renzo Guerrini Renzo Guerrini has nothing to disclose.
Mahnaz Asgharnejad, PharmD Mahnaz Asgharnejad, PharmD has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Mahnaz Asgharnejad, PharmD has stock in GlaxoSmithKline. Mahnaz Asgharnejad, PharmD has stock in Takeda Pharmaceuticals.
Manoj Malhotra, MD Dr. Malhotra has received personal compensation for serving as an employee of Eisai.
Magdy H. Selim, MD, PhD Dr. Selim has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedRhythms Inc..
Aninda Acharya, MD Dr. Acharya has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Acharya has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Acharya has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva.
Clifford R. Jack, Jr., MD The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic.
Shyam Visweswaran, MD The institution of Dr. Visweswaran has received research support from NIH.
Tamara M. Pringsheim, MD, FAAN The institution of Dr. Pringsheim has received research support from Canadian Institutes of Health Research. The institution of Dr. Pringsheim has received research support from Azrieli Accelerator.
Jan Nils Lycke, MD Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Lycke has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Lycke has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GeNeuro. The institution of Dr. Lycke has received research support from Sanofi.
Robert T. Wechsler, MD, PhD, FAAN The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Otsuka. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aquestive. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Engage. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Greenwich. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eliem. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epalex. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Engrail. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurona. Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Sunovion. Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Greenwich. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai. Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aquestive. Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science. Dr. Wechsler has a non-compensated relationship as a Board President with Epilepsy Foundation of Idaho that is relevant to AAN interests or activities.
Dawn O. Kleindorfer, MD, FAAN Dr. Kleindorfer has nothing to disclose.
Keith A. Josephs, Jr., MD, FAAN Dr. Josephs has nothing to disclose.
Pooja Khatri, MD, FAAN The institution of Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lumosa. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bayer. The institution of Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Diamedica. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Basking Biosciences. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Khatri has received research support from Cerenovus. Dr. Khatri has received publishing royalties from a publication relating to health care.
Laurie J. Ozelius, PhD The institution of Dr. Ozelius has received research support from NIH. Dr. Ozelius has received intellectual property interests from a discovery or technology relating to health care.
Deborah Raymond The institution of Ms. Raymond has received research support from NIH.
Caterina Mainero, MD, PhD The institution of Dr. Mainero has received research support from Genentech.
Netta Levin, MD, PhD Dr. Levin has nothing to disclose.
Karla Patricia Figueroa Ms. Figueroa has nothing to disclose.
Joao Antonio Gomes, MD Dr. Gomes has nothing to disclose.
Nizar Souayah, MD, FAAN Dr. Souayah has received publishing royalties from a publication relating to health care.
Kelly G. Knupp, MD Dr. Knupp has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for zogenix. Dr. Knupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for encoded. Dr. Knupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for stoke. The institution of Dr. Knupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW pharmaceuticals. Dr. Knupp has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsy Research.
Rana R. Said, MD, FAAN Dr. Said has nothing to disclose.
Susan Gauthier, DO Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gnenetech. The institution of Dr. Gauthier has received research support from Genentech.
Tony Wu, MD, PhD Dr. Wu has nothing to disclose.
Juan Fernando Gongora Rivera, MD, MSc Dr. Gongora Rivera has nothing to disclose.
Michael H. Lev, MD Michael H. Lev, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda, Roche-Genetech. The institution of Michael H. Lev, MD has received research support from GE. Michael H. Lev, MD has received publishing royalties from a publication relating to health care.
Wendyl J. D'Souza, MD, MBChB Dr. D'Souza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LivaNova, Eisai, UCB, Tilray. Dr. D'Souza has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB Pharma, Eisai Pharmaceutical. Dr. D'Souza has stock in Epiminder. The institution of Dr. D'Souza has received research support from UCB Pharma. The institution of Dr. D'Souza has received research support from Eisai Pharmaceutical.
Benjamin M. Greenberg, MD, FAAN Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/ROche. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Clene. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle Pharma. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. Dr. Greenberg has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Siegel Rare Neuroimmune Association. Dr. Greenberg has stock in GenrAb. Dr. Greenberg has stock in Clene. The institution of Dr. Greenberg has received research support from CLENE Nanomedicine. The institution of Dr. Greenberg has received research support from Anokion. The institution of Dr. Greenberg has received research support from Regeneron. Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Greenberg has received publishing royalties from a publication relating to health care.
Francesca Bagnato, MD Dr. Bagnato has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyne. Dr. Bagnato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Bagnato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jenseen. Dr. Bagnato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merk-Serono.
Charles R.G. Guttmann Charles R.G. Guttmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sintetica SA. Charles R.G. Guttmann has received stock or an ownership interest from Alnylam. Charles R.G. Guttmann has received stock or an ownership interest from Roche. Charles R.G. Guttmann has received stock or an ownership interest from Novartis. Charles R.G. Guttmann has received stock or an ownership interest from Arrowhead Pharmaceuticals. Charles R.G. Guttmann has received stock or an ownership interest from Protalix. Charles R.G. Guttmann has received stock or an ownership interest from Promethee. Charles R.G. Guttmann has received stock or an ownership interest from GSK. Charles R.G. Guttmann has received stock or an ownership interest from Sangamo. Charles R.G. Guttmann has received stock or an ownership interest from Alcon. Charles R.G. Guttmann has received stock or an ownership interest from Cocrystal Pharma. The institution of Charles R.G. Guttmann has received research support from NIH. The institution of Charles R.G. Guttmann has received research support from McGill University. The institution of Charles R.G. Guttmann has received research support from National Multiple Sclerosis Society. The institution of Charles R.G. Guttmann has received research support from BrightFocus Foundation. The institution of Charles R.G. Guttmann has received research support from National Multiple Sclerosis Society. The institution of Charles R.G. Guttmann has received research support from University of Connecticut Health Center. The institution of Charles R.G. Guttmann has received research support from U.S. Office of Naval Research.
Giuseppe Magnani Giuseppe Magnani has nothing to disclose.
David Pitt, MD Dr. Pitt has nothing to disclose.
Maria Assunta Rocca Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Todd J. Schwedt, MD, FAAN Dr. Schwedt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Allergan. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Schwedt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Schwedt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Schwedt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biodelivery Science. Dr. Schwedt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Collegium. Dr. Schwedt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Linpharma. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Schwedt has received personal compensation in the range of $0-$499 for serving as a Consultant for Amgen. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scilex. Dr. Schwedt has stock in Aural Analytics. Dr. Schwedt has stock in Nocira. The institution of Dr. Schwedt has received research support from Amgen. The institution of Dr. Schwedt has received research support from National Institutes of Health. The institution of Dr. Schwedt has received research support from United States Department of Defense. The institution of Dr. Schwedt has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Schwedt has received research support from SPARK Neuro. The institution of Dr. Schwedt has received research support from Henry Jackson Foundation. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received publishing royalties from a publication relating to health care.
Matthew L. Flaherty, MD Dr. Flaherty has received personal compensation for serving as an employee of Sense Diagnostics, Inc. Dr. Flaherty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boeringher Engelheim. Dr. Flaherty has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Dr. Flaherty has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Alexion. Dr. Flaherty has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various law firms. Dr. Flaherty has stock in Sense Diagnostics, Inc. The institution of Dr. Flaherty has received research support from NINDS. Dr. Flaherty has received intellectual property interests from a discovery or technology relating to health care.
Darin T. Okuda, MD, FAAN Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RVL Pharmaceuticals, Inc.. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Okuda has received research support from Novartis. The institution of Dr. Okuda has received research support from EMD Serono. Dr. Okuda has received intellectual property interests from a discovery or technology relating to health care.
Susan M. Bowyer, PhD Dr. Bowyer has nothing to disclose.
Jaime Imitola, MD, FAAN Dr. Imitola has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis . The institution of Dr. Imitola has received research support from biogen. Dr. Imitola has a non-compensated relationship as a Board Member with National MS Society that is relevant to AAN interests or activities. Dr. Imitola has a non-compensated relationship as a Committee Member with International Society for Stem Cell Research that is relevant to AAN interests or activities.
Bruce D. Trapp, PhD Dr. Trapp has received personal compensation for serving as an employee of Renovo Neural Inc.. The institution of Dr. Trapp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Therini Bio, Inc.. Dr. Trapp has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Trapp has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Disarm Therapeutics. Dr. Trapp has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kantonsspital Aarau AG. Dr. Trapp has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for triMS.online. The institution of Dr. Trapp has received research support from Genzyme Corporation. The institution of Dr. Trapp has received research support from ALS Association. The institution of Dr. Trapp has received research support from National Institute of Neurological Disorders and Stroke.
M. Antonietta Volonte, MD Dr. Volonte has nothing to disclose.
Kim I. Bishop, PhD Dr. Bishop has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for zogenix. Dr. Bishop has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Medtronic. Dr. Bishop has stock in zogenix.
Lisa Herring Sovory, MD Dr. Sovory has nothing to disclose.
Wouter Schievink, MD Dr. Schievink has nothing to disclose.
Naomi Lubarr, MD Dr. Lubarr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for applied therapeutics.
Arun Venkatesan, MD, PhD Dr. Venkatesan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. The institution of Dr. Venkatesan has received research support from NIH. The institution of Dr. Venkatesan has received research support from MSRCF. The institution of Dr. Venkatesan has received research support from U.S. DOD.
Daniel Harrison, MD Dr. Harrison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Dr. Harrison has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American College of Physicians. The institution of Dr. Harrison has received research support from Roche-Genentech. Dr. Harrison has received publishing royalties from a publication relating to health care.
Cornelia Laule, PhD The institution of Dr. Laule has received research support from Multiple Sclerosis Society of Canada. The institution of Dr. Laule has received research support from Natural Sciences and Engineering Research Council of Canada (NSERC). The institution of Dr. Laule has received research support from International Collaboration on Repair Discoveries (ICORD).
Mary M. Machulda, PhD The institution of Dr. Machulda has received research support from NIH.
Olga Klepitskaya, MD, FAAN Dr. Klepitskaya has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc.
Stacey Clardy, MD, PhD, FAAN Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from Sumaira Foundation for NMO. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with Barrow Neurological Institute. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with Beaumont Health. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with Stanford. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with Cleveland Clinic.
Jeremiah M. Scharf, MD, PhD The institution of Dr. Scharf has received research support from the TLC Foundation for Body-Focused Repetitive Behaviors. Dr. Scharf has received personal compensation in the range of $500-$4,999 for serving as a Speaker for a TAA/CDC Family Day Symposium with the Tourette Association of America. Dr. Scharf has a non-compensated relationship as a Scientific Advisory Board Member with the Tourette Association of America that is relevant to AAN interests or activities.
Roland G. Henry, PhD Dr. Henry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MEDDAY. Dr. Henry has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Henry has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Henry has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi/Genzyme.
Sharyl R. Martini, MD,PhD Dr. Martini has nothing to disclose.
Seth A. Smith, PhD Dr. Smith has nothing to disclose.
Rima Nabbout No disclosure on file
Lauren Hachmann Sansing, MD Dr. Sansing has nothing to disclose.
David J. Houghton, MD Dr. Houghton has nothing to disclose.
Daniel Reich, MD,PhD Dr. Reich has received research support from NIH. The institution of Dr. Reich has received research support from Adelson Medical Research Foundation. The institution of Dr. Reich has received research support from Sanofi-Genzyme. The institution of Dr. Reich has received research support from Abata Therapeutics. The institution of Dr. Reich has received research support from National Multiple Sclerosis Society. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with PeerView. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with AcademicCME. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Integrity. Dr. Reich has a non-compensated relationship as a Advisor with Sanofi-Genzyme that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Board of Directors with ACTRIMS that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Abata Therapeutics that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with American Brain Foundation that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with University of Basel RC2NB that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Multiple Sclerosis Society of Canada that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Tuscan Doctorate in Neuroscience that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Editorial Board with Multiple Sclerosis Journal that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Biohaven that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Sana that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Merck KGaA EMD Serono that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Bristol-Meyers Squibb that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with ChemoCentryx that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Hyperfine that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Imaginab that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Perceptive that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Annexon that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Philips that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Siemens that is relevant to AAN interests or activities.
Parthasarathy Thirumala, MD, FAAN The institution of Dr. Thirumala has received research support from University of Pittsburgh.
Michelle L. Mauermann, MD, FAAN The institution of Dr. Mauermann has received research support from IONIS. The institution of Dr. Mauermann has received research support from Alnylam. Dr. Mauermann has received publishing royalties from a publication relating to health care.
Sarah E. Berini, MD Dr. Berini has nothing to disclose.
Shane Smyth, MD Dr. Smyth has nothing to disclose.
Jason S. Mackey, MD Dr. Mackey has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for legal firms. The institution of Dr. Mackey has received research support from PCORI.
Suparna R. Krishnaiengar, MD Dr. Krishnaiengar has nothing to disclose.
Daniel Antoniello, MD Dr. Antoniello has nothing to disclose.
Federica Agosta Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.
Michael D. Fox, MD, PhD Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley.
Nilufer Taner, MD, PhD, FAAN The institution of Dr. Taner has received research support from NIH.
Kevin N. Sheth, MD, FAAN Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.
Christina Azevedo, MD, FAAN Dr. Azevedo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi Genzyme. Dr. Azevedo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Azevedo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Azevedo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Azevedo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. Azevedo has received research support from National Multiple Sclerosis Society. The institution of Dr. Azevedo has received research support from National Institutes of Health/National Institutes of Neurological Disorders and Stroke. The institution of Dr. Azevedo has received research support from National Multiple Sclerosis Society.
Brandon P. Foreman, MD Dr. Foreman has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB Pharma Inc. Dr. Foreman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell, Inc. Dr. Foreman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sage Therapeutics. Dr. Foreman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus Pharmaceuticals. Dr. Foreman has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB Pharma Inc.. The institution of Dr. Foreman has received research support from DOD/AMRMC. The institution of Dr. Foreman has received research support from Biogen, Inc.. The institution of Dr. Foreman has received research support from DOD/AFRL. The institution of Dr. Foreman has received research support from NSF SCH:INT. The institution of Dr. Foreman has received research support from NIH/NIBIB. The institution of Dr. Foreman has received research support from DOD/JWMRP. The institution of Dr. Foreman has received research support from Marinus Pharmaceuticals. Dr. Foreman has received personal compensation in the range of $500-$4,999 for serving as a Honoraria with Natus Medical Incorporated. Dr. Foreman has received personal compensation in the range of $500-$4,999 for serving as a Honoraria with Ceribell, Inc.. Dr. Foreman has received personal compensation in the range of $0-$499 for serving as a Peer-to-peer program honoraria with Marinus Pharmaceuticals.
Avinash Chandra, MD Dr. Chandra has nothing to disclose.
Cristina Granziera, MD, PhD Dr. Granziera has nothing to disclose.
Richard Stark, FRACP, MBBS Dr. Stark has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Stark has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Stark has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Stark has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Stark has stock in CSL. Dr. Stark has stock in Multiple ASX listed (non-medical) companies. Dr. Stark has received personal compensation in the range of $10,000-$49,999 for serving as a TCMC Committee chair with AMA Victoria.
Michael Hutchinson, MD Dr. Hutchinson has nothing to disclose.
Stephen Bevan Shrewsbury, MD Dr. Shrewsbury has received personal compensation for serving as an employee of Impel NeuroPharma. Dr. Shrewsbury has received stock or an ownership interest from Impel NeuroPharma.
Abu Nasar, MD Abu Nasar, MD has nothing to disclose.
Alex Rovira Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofy. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Alex Rovira has stock in Tensor Medical.
Kathleen Alwell No disclosure on file
Timothy Cunningham Timothy Cunningham has received intellectual property interests from a discovery or technology relating to health care.
Timothy Lesnick Timothy Lesnick has received personal compensation for serving as an employee of Mayo Clinic.
Stephen Weigand Stephen Weigand has nothing to disclose.
Jane Khoury Jane Khoury has nothing to disclose.
Mary Haverbusch The institution of Mary Haverbusch has received research support from NINDS R01NS030678.
Minerva Carrasquillo Minerva Carrasquillo has nothing to disclose.
Robert Spinner Robert Spinner has received personal compensation for serving as an employee of Mayo Clinic.
Kerstin Hellwig Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for INC research . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer . The institution of Kerstin Hellwig has received research support from Roche . The institution of Kerstin Hellwig has received research support from Merck . The institution of Kerstin Hellwig has received research support from Biogen. The institution of Kerstin Hellwig has received research support from Genzyme . The institution of Kerstin Hellwig has received research support from Novartis . The institution of Kerstin Hellwig has received research support from TEVA.
Kevin O'Connor Kevin O'Connor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Kevin O'Connor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Kevin O'Connor has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Viela Bio. Kevin O'Connor has stock in Cabaletta.
Paola Valsasina Paola Valsasina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ACCMED.
Wei Liu, MD Dr. Liu has nothing to disclose.
Sameer Chhibber, MD The institution of Dr. Chhibber has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Chhibber has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx.
Angela Yvonne Peters, MD The institution of Dr. Peters has received research support from NIH.
Mathew J. Reeves, PhD, BVSc Mathew J. Reeves, PhD, BVSc has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association.
DaiWai Olson DaiWai Olson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Minnetronix. The institution of DaiWai Olson has received research support from Neuroptics. The institution of DaiWai Olson has received research support from Ceribell.
Leo Wolansky, MD The institution of Dr. Wolansky has received research support from Guerbet.
Elspeth Hutton, MD The institution of Dr. Hutton has received research support from Lundbeck. The institution of Dr. Hutton has received research support from Daewoong Pharmaceuticals . The institution of Dr. Hutton has received research support from Xalud. The institution of Dr. Hutton has received research support from Ipsen. The institution of Dr. Hutton has received research support from Abbvie. The institution of Dr. Hutton has received research support from Cerecin. Dr. Hutton has a non-compensated relationship as a Board Member with Brain Foundation (Vic) that is relevant to AAN interests or activities. Dr. Hutton has a non-compensated relationship as a President-elect with Australian and New Zealand Headache Society that is relevant to AAN interests or activities.
Paola Caroppo Paola Caroppo has nothing to disclose.
Elisabetta Pagani Elisabetta Pagani has nothing to disclose.
Jean Paul Vonsattel Jean Paul Vonsattel has nothing to disclose.
Adi Vaknin-Dembinsky, MD No disclosure on file
Bonnie Glanz The institution of Ms. Glanz has received research support from CMSC. The institution of Ms. Glanz has received research support from NIH.
Olga Ciccarelli, PhD, FRCP Prof. Ciccarelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Ciccarelli has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Prof. Ciccarelli has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEUROLOGY Journal.
Daniel Ontaneda, MD, PhD, FAAN Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech/Roche. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech/Roche. The institution of Dr. Ontaneda has received research support from NIH. The institution of Dr. Ontaneda has received research support from PCORI. The institution of Dr. Ontaneda has received research support from NMSS. The institution of Dr. Ontaneda has received research support from Genetech.
Jayawant Narayan Mandrekar, PhD Dr. Mandrekar has nothing to disclose.
Jennifer Louise Whitwell, PhD Dr. Whitwell has nothing to disclose.
Dinesh Kumar Dinesh Kumar has received personal compensation for serving as an employee of Eisai.
Nicholas A. Frost, MD, PhD The institution of Dr. Frost has received research support from Simons Foundation. The institution of Dr. Frost has received research support from National Institutes of Health.
Daniel DiCapua, MD, FAAN Dr. DiCapua has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. DiCapua has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx.
David Dredge, MD Dr. Dredge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Optum Rx. The institution of Dr. Dredge has received research support from NIH.
Paul G. Mathew, MD, FAAN, FAHS Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie/Allergan. Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Mathew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven/Pfizer. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Upsher Smith. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for CRICO.
Opeolu Adeoye Opeolu Adeoye has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Nico Corp. Opeolu Adeoye has stock in Sense Diagnostics. The institution of Opeolu Adeoye has received research support from NIH/NINDS.
Esra Battaloglu Esra Battaloglu has nothing to disclose.
Richard J. Nowak, MD Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bio. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cour Pharma. The institution of Dr. Nowak has received research support from Ra Pharma. The institution of Dr. Nowak has received research support from Alexion . The institution of Dr. Nowak has received research support from Momenta . The institution of Dr. Nowak has received research support from Immunovant . Dr. Nowak has received research support from argenx. Dr. Nowak has received research support from Viela Bio . Dr. Nowak has a non-compensated relationship as a Member of the Board of Directors with Myasthenia Gravis Foundation of America (MGFA) that is relevant to AAN interests or activities.
Teneille Gofton, MD The institution of Dr. Gofton has received research support from Government of Canada. The institution of Dr. Gofton has received research support from Canadian Institutes of Health Research. The institution of Dr. Gofton has received research support from Academic Medical Organisation of Southwestern Ontario. Dr. Gofton has a non-compensated relationship as a Medical Advisory Board Member with NORSE Institute that is relevant to AAN interests or activities.
Babak Navi, MD Dr. Navi has nothing to disclose.
Halina White, MD MA BA Dr. White has nothing to disclose.
JaNean Engelstad JaNean Engelstad has nothing to disclose.
Justin Thorson, MD Dr. Thorson has nothing to disclose.
Joachim Krauss Joachim Krauss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inomed. Joachim Krauss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for aleva. Joachim Krauss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston.
Mai Yamakawa, MD Dr. Yamakawa has nothing to disclose.
Aurelia Poujois No disclosure on file
Bernhard Steinhoff Bernhard Steinhoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arvelle. Bernhard Steinhoff has received personal compensation in the range of $0-$499 for serving as a Consultant for B.Braun Melsungen. Bernhard Steinhoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Bernhard Steinhoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Bernhard Steinhoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuraxpharm. Bernhard Steinhoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Precisis. Bernhard Steinhoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arvelle. Bernhard Steinhoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Bernhard Steinhoff has received research support from UCB. The institution of Bernhard Steinhoff has received research support from Eisai. The institution of Bernhard Steinhoff has received research support from SK LIfe Science.
Prashanthi Vemuri, PhD Dr. Vemuri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Miller Medical Communications Inc.. The institution of Dr. Vemuri has received research support from NIH.
Hooman Kamel, MD Dr. Kamel has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Kamel has received personal compensation in the range of $50,000-$99,999 for serving as a Endpoint adjudication committee with Boehringer-Ingelheim.
Marcia E. Morita-Sherman, MD An immediate family member of Dr. Morita-Sherman has received personal compensation for serving as an employee of Forrester Research. Dr. Morita-Sherman has received personal compensation for serving as an employee of Eisai Inc.. An immediate family member of Dr. Morita-Sherman has stock in Forrester Research. The institution of Dr. Morita-Sherman has received research support from Cleveland Clinic.
Shibeshih Belachew, MD Dr. Belachew has received personal compensation for serving as an employee of Biogen Inc. Dr. Belachew has received stock or an ownership interest from Biogen Inc.
Jiwon Oh, MD, FAAN Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. The institution of Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen-Idec. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD-Serono. Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Dr. Oh has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen-Idec. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Oh has received research support from Biogen-Idec. The institution of Dr. Oh has received research support from Roche.
Nils Petersen, MD Dr. Petersen has received research support from NIH.
Roshini Jain Roshini Jain has received personal compensation for serving as an employee of Boston Scientific. Roshini Jain has received stock or an ownership interest from Boston Scientific.
Lisa T. Emrick, MD Dr. Emrick has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Arkema. The institution of Dr. Emrick has received research support from Lysogene. The institution of Dr. Emrick has received research support from PTC. The institution of Dr. Emrick has received research support from Roche. The institution of Dr. Emrick has received research support from NIH.
Anne M. Morse, DO Dr. Morse has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Morse has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Avadel. Dr. Morse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony Biosciences. Dr. Morse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alkermes. Dr. Morse has received personal compensation in the range of $0-$499 for serving as a Consultant for NLS Pharmaceuticals. Dr. Morse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Morse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Morse has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Morse has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avadel. Dr. Morse has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Morse has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Avadel. Dr. Morse has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Hayes solicitors. The institution of Dr. Morse has received research support from NIH. Dr. Morse has received publishing royalties from a publication relating to health care. Dr. Morse has received personal compensation in the range of $50,000-$99,999 for serving as a CEO with DAMM Good Sleep, LLC.
Mia T. Minen, MD, FAAN Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pain Medicine Journal. The institution of Dr. Minen has received research support from NIH. Dr. Minen has received intellectual property interests from a discovery or technology relating to health care. Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a First Contact-Primary Care Advisory Board Member with American Headache Society . Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PCORI grant on migraine evidence based map for stakeholders with ECRI .
Christopher Hemond, MD Dr. Hemond has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for VIVIO Health. Dr. Hemond has stock in VIVIO Health. The institution of Dr. Hemond has received research support from Consorium of Multiple Sclerosis Centers. The institution of Dr. Hemond has received research support from National Multiple Sclerosis Society. The institution of Dr. Hemond has received research support from National Center for Advancing Translational Sciences, National Institutes of Health. The institution of Dr. Hemond has received research support from University of Massachusetts Memorial Medical Center. The institution of Dr. Hemond has received research support from National Institute Of Neurological Disorders And Stroke of the National Institutes of Health. Dr. Hemond has received personal compensation in the range of $0-$499 for serving as a Member of Data Safety and Monitoring Board with National Institute Of Neurological Disorders And Stroke of the National Institutes of Health.
Maia Gomez Schneider No disclosure on file
Daniel Pastula, MD, MHS, FAAN Dr. Pastula has nothing to disclose.
Jiangyong Min, MD Dr. Min has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott . Dr. Min has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic .
Elisabeth Wilde Elisabeth Wilde has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neuropsychology. The institution of Elisabeth Wilde has received research support from CDMRP/DoD. The institution of Elisabeth Wilde has received research support from VA. The institution of Elisabeth Wilde has received research support from NIH. The institution of Elisabeth Wilde has received research support from Cohen Veteran Biosciences.
Laura Airas, MD, PhD The institution of Dr. Airas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. The institution of Dr. Airas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Michel C. Shamy, MD Dr. Shamy has nothing to disclose.
Stella Leock Ngo, PhD Dr. Ngo has received personal compensation for serving as an employee of Eisai Inc..
Khosro Farhad, MD, FAAN Dr. Farhad has nothing to disclose.
Jose Manuel Garcia Dominguez Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for merck. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Almirall.
Ingrid E. Scheffer, AO, MBBS, PhD, FRACP Dr. Scheffer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven Pharmaceuticals, Inc. Dr. Scheffer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerecin Inc. The institution of Dr. Scheffer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epilepsy Consortium. Dr. Scheffer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Longboard Pharmaceuticals . Dr. Scheffer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bellberry Ltd. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Shenzhen Sanming Development Grant . The institution of Dr. Scheffer has received research support from Einstein Visiting Fellowship. Dr. Scheffer has received intellectual property interests from a discovery or technology relating to health care. Dr. Scheffer has received intellectual property interests from a discovery or technology relating to health care. Dr. Scheffer has received intellectual property interests from a discovery or technology relating to health care. Dr. Scheffer has received personal compensation in the range of $500-$4,999 for serving as a Speaker honoraria with Akumentis. Dr. Scheffer has received personal compensation in the range of $500-$4,999 for serving as a Travel/Conference/Speaker honoraria with Biocodex. Dr. Scheffer has received personal compensation in the range of $500-$4,999 for serving as a Travel/Conference/Speaker honoraria with BioMarin. Dr. Scheffer has received personal compensation in the range of $500-$4,999 for serving as a Speaker honoraria with Chiesi. Dr. Scheffer has received personal compensation in the range of $500-$4,999 for serving as a Travel/Conference/Speaker honoraria with Eisai. Dr. Scheffer has received personal compensation in the range of $500-$4,999 for serving as a Travel/Conference with Encoded Therapeutics. Dr. Scheffer has received personal compensation in the range of $500-$4,999 for serving as a Speaker honoraria with Liva Nova. Dr. Scheffer has received personal compensation in the range of $500-$4,999 for serving as a Speaker honoraria with Nutricia. Dr. Scheffer has received personal compensation in the range of $500-$4,999 for serving as a Travel/Conference/Speaker honoraria with Stoke Therapeutics. Dr. Scheffer has received personal compensation in the range of $500-$4,999 for serving as a Travel/Conference/Speaker honoraria with UCB. Dr. Scheffer has received personal compensation in the range of $500-$4,999 for serving as a Speaker honoraria with Zuellig Pharma Inc.. Dr. Scheffer has a non-compensated relationship as a Trial Investigator with Anavex Life Sciences that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Cerebral Therapeutics that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Cerecin that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Cereval Therapeutics that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Eisai that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Scientific Advisory Board, Trial investigator with Encoded Therapeutics that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with EpiMinder Inc that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with ES-Therapeutics that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Knopp Biosciences that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Marinus Pharmaceuticals that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Neurocrine BioSciences that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Ovid Therapeutics that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with SK Life Science that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator, Scientific Advisory Board with Takeda Pharmaceuticals that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Xenon Pharmaceuticals that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Zogenix that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with Neurology that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with Epilepsy Currents that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with Epileptic Disorders that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with The Lancet Neurology that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with Progress in Epileptic Disorders series that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Director with Australian Academy of Health and Medical Sciences that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Director with Royal Society (Australia). that is relevant to AAN interests or activities.
Markus Reuber Markus Reuber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Angellini Pharma. Markus Reuber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharma. Markus Reuber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. The institution of Markus Reuber has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA MedTech. Markus Reuber has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Markus Reuber has received research support from UCB Pharma. Markus Reuber has received publishing royalties from a publication relating to health care.
Felipe De Los Rios La Rosa, MD Dr. De Los Rios La Rosa has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca.
Simona Ferioli, MD Dr. Ferioli has nothing to disclose.
Bhooma Rajagopalan Aravamuthan, MD, PhD Dr. Aravamuthan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine Biosciences. An immediate family member of Dr. Aravamuthan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SK Life Science, Inc.. Dr. Aravamuthan has received research support from National Institute of Neurological Disorders and Stroke. Dr. Aravamuthan has received publishing royalties from a publication relating to health care.
Gyanendra Kumar, MD, FAAN Dr. Kumar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Oculus Imaging. Dr. Kumar has received personal compensation in the range of $0-$499 for serving as a Medical Consultant with AZMB. Dr. Kumar has received personal compensation in the range of $0-$499 for serving as a Medical Consultant with AZMB.
Amanda Lee Piquet, MD, FAAN The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. The institution of Dr. Piquet has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. The institution of Dr. Piquet has received personal compensation in the range of $0-$499 for serving as a Consultant for EMD Serono. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sands Anderson PC. Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Joe Jones Law Firm. The institution of Dr. Piquet has received research support from Rocky Mountain MS Center. The institution of Dr. Piquet has received research support from Novartis. The institution of Dr. Piquet has received research support from Abbvie. The institution of Dr. Piquet has received research support from Roche/Genentech. The institution of Dr. Piquet has received research support from NYU. The institution of Dr. Piquet has received research support from Anokion. The institution of Dr. Piquet has received research support from UCB . The institution of Dr. Piquet has received research support from Foundation for Sarcoidosis. Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Litigative Consultant with US-Dept HHS/DICP. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Autoimmune Encephalitis Alliance (AEA) that is relevant to AAN interests or activities. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Stiff Person Syndrome Research Foundation (SPSRF) that is relevant to AAN interests or activities.
Jonathan Graff-Radford, MD, FAAN Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai.
Yoshinori Nishimoto Yoshinori Nishimoto has received research support from Japan Society for the Promotion of Science.
Virginia Andrea Pujol Lereis, MD Dr. Pujol Lereis has nothing to disclose.
Christopher Schwarz Christopher Schwarz has received personal compensation for serving as an employee of Mayo Clinic. The institution of Christopher Schwarz has received research support from NIH.
Yang Xuan No disclosure on file
Danny Bega, MD Dr. Bega has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GE Healthcare. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WebMD. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Acorda Therapeutics. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine Biosciences. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ACTN / ANA. The institution of Dr. Bega has received research support from Huntington Disease Society of America. The institution of Dr. Bega has received research support from Parkinson Foundation.
Adam S. Jasne, MD Dr. Jasne has nothing to disclose.
Scott Siegert Mr. Siegert has received personal compensation for serving as an employee of Neurocrine Biosciences. Mr. Siegert has stock in Neurocrine Biosciences.
Alicia M. Zukas, MD Dr. Zukas has nothing to disclose.
John Probasco, MD, FAAN Dr. Probasco has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch Neurology. The institution of Dr. Probasco has received research support from Roche/Genentech.
Muhib Khan, MD, FAAN The institution of Dr. Khan has received research support from NINDS. The institution of Dr. Khan has received research support from Genentech. The institution of Dr. Khan has received research support from Spectrum Health-MSU alliance. Dr. Khan has received research support from NIH.
Vasileios-Arsenios Lioutas, MD Dr. Lioutas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Qmetis. Dr. Lioutas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mindray. The institution of Dr. Lioutas has received research support from NIH. The institution of Dr. Lioutas has received research support from Alzheimer's Association.
Christopher Hahn, MD Dr. Hahn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea. Dr. Hahn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Anylim.
Jimmy Holder, MD Dr. Holder has received personal compensation in the range of $0-$499 for serving as a Consultant with Stoke Pharmaceutical.
Roland Dominic Jamora Roland Dominic Jamora has received personal compensation in the range of $500-$4,999 for serving as a Consultant for torrent. Roland Dominic Jamora has received research support from CCXDP.
Michael Stefan Oldham, MD, MPH Dr. Oldham has received personal compensation for serving as an employee of Praxis Precision Medicines.
Ava L. Liberman, MD The institution of Dr. Liberman has received research support from NIH.
David Cachia, MD Dr. Cachia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for RedHill Biopharma Ltd. Dr. Cachia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GuidePoint Global LLC. Dr. Cachia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dedham Group. Dr. Cachia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Massachusetts Neurological Society.
Z Paige L'Erario, MD, LMSW Dr. L'Erario has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ohio State University, University of Colorado, Sacred Heart University, The LOFT LGBT Community Center, Oregon Stroke Conference, Child Neurology Society. Dr. L'Erario has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Weiss Law. Dr. L'Erario has received publishing royalties from a publication relating to health care.
Nawaz Hack, MD Dr. Hack has nothing to disclose.
Hacer Durmus, MD Dr. Durmus has nothing to disclose.
Charles Maitland Charles Maitland has nothing to disclose.
Vineet Punia, MD Dr. Punia has nothing to disclose.
Gerard A. Gioia, MD Dr. Gioia has received personal compensation in the range of $0-$499 for serving as a Consultant for Global Pharma Consultancy. Dr. Gioia has received publishing royalties from a publication relating to health care.
Stefan Bittner Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Biogen Idec. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Merck Healthcare. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Novartis. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Roche. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Sanofi. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Bristol-Meyer-Squibbs. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Teva.
Pedro Rosa Neto, MD, PhD The institution of Dr. Rosa Neto has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk.
Yi-Cheng Zhu, MD, PhD Dr. Zhu has nothing to disclose.
Massimiliano Calabrese Massimiliano Calabrese has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharma. Massimiliano Calabrese has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Serono. Massimiliano Calabrese has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Massimiliano Calabrese has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis Pharma. Massimiliano Calabrese has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Massimiliano Calabrese has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Massimiliano Calabrese has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS Celgene. The institution of Massimiliano Calabrese has received research support from Roche.
Elisa Canu The institution of Elisa Canu has received research support from Italian Ministry of Health .
Carol Mathews The institution of Carol Mathews has received research support from NIH. Carol Mathews has received publishing royalties from a publication relating to health care.
Lori B. Chibnik Lori B. Chibnik has nothing to disclose.
Enrica Cavedo No disclosure on file
James E. Siegler, III, MD Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke: Vascular and Interventional Neurology. Dr. Siegler has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various medicolegal cases. The institution of Dr. Siegler has received research support from Viz.ai.
J. Helen Cross Dr. Cross has nothing to disclose.
Derek Debicki, MD Dr. Debicki has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Canada Inc.. The institution of Dr. Debicki has received research support from Academic Medical Association of Southwestern Ontario. The institution of Dr. Debicki has received research support from Western BrainScan. The institution of Dr. Debicki has received research support from Lawson Research. The institution of Dr. Debicki has received research support from Canadian Institutes of Health Research.
Moshe Albert Mizrahi, MD, FAAN Dr. Mizrahi has nothing to disclose.
Stacie Leigh Demel, DO Dr. Demel has nothing to disclose.
Marisela E. Dy-Hollins, MD, MSCR, FAAN Dr. Dy-Hollins has stock in TraceFemcare. The institution of Dr. Dy-Hollins has received research support from CNCDP-K12.
Mehmood Rashid, MD Dr. Rashid has nothing to disclose.
Gregory N. Beatch, PhD Dr. Beatch has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc. Dr. Beatch has stock in Xenon Pharmaceuticals Inc. Dr. Beatch has received intellectual property interests from a discovery or technology relating to health care.
Melinda S. Martin, PhD Dr. Martin has received personal compensation for serving as an employee of UCB. Dr. Martin has received stock or an ownership interest from UCB.
Jenny Wilson, MD Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Nevada Medical Board and Evans and Dixon attorneys at law. The institution of Dr. Wilson has received research support from Teva. Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as a Rite question reviewer with AAN.
Adam De Havenon, MD Dr. De Havenon has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has stock in Certus. Dr. De Havenon has stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care.
Katherine Emily Leaver, MD Dr. Leaver has nothing to disclose.
Rose Gelineau-Morel, MD Dr. Gelineau-Morel has nothing to disclose.
Francesca Caso, MD Dr. Caso has nothing to disclose.
Jennifer Anne Vermilion, MD The institution of Dr. Vermilion has received research support from Tourette Association of America, American Academy of Neurology and American Brain Foundation. The institution of Dr. Vermilion has received research support from Centers for Disease Control.
Tony Daniels Tony Daniels has received personal compensation for serving as an employee of UCB . Tony Daniels has received stock or an ownership interest from UCB.
Marcel Maya Marcel Maya has nothing to disclose.
Elyse Park Elyse Park has received publishing royalties from a publication relating to health care.
Paolo Preziosa Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb . Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Antonio Scalfari, MD Dr. Scalfari has nothing to disclose.
Russell T. Shinohara Mr. Shinohara has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Medical Association. The institution of Mr. Shinohara has received research support from National Institutes of Health. The institution of Mr. Shinohara has received research support from National Multiple Sclerosis Society.
Eugen Trinka Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Böhringer Ingelheim. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Everpharma. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Liva-Nova. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Newbridge. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GW Pharmaceuticals. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Marinus. The institution of Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arvelle. Eugen Trinka has received research support from Austrian Science Fund (FWF). Eugen Trinka has received research support from Österreichische Nationalbank. Eugen Trinka has received research support from European Union. Eugen Trinka has received research support from GSK. Eugen Trinka has received research support from Biogen. Eugen Trinka has received research support from Eisai. Eugen Trinka has received research support from Novartis. Eugen Trinka has received research support from Red Bull. Eugen Trinka has received research support from Bayer. Eugen Trinka has received research support from UCB. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a other with Neuroconsult Ges.m.b.H..
Vicente Villanueva Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIAL. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW pharmaceutical. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arvelle. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EISAI. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIAL. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GW pharma. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Arvelle.
Paul Yushkevich Paul Yushkevich has nothing to disclose.
Leana Doherty, MD Dr. Doherty has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM.
Michelle Del Castillo DeJesus Brazitis, MD Dr. DeJesus Brazitis has nothing to disclose.
Ugur Uygunoglu Ugur Uygunoglu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Turkey . The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen Idec/Gen Pharma of Turkey.
Brian Pfister Dr. Pfister has received personal compensation for serving as an employee of PTC Therapeutics. Dr. Pfister has stock in PTC Therapeutics.
Shaheen E. Lakhan, MD, PhD, MEd, FAAN Dr. Lakhan has received personal compensation for serving as an employee of Zogenix, Fern Health, Thriveworks, The Learning Corp, Click Therapeutics. Dr. Lakhan has received personal compensation in the range of $1,000,000+ for serving as a Consultant for Shaheen Lakhan, MD, PhD, LLC. Dr. Lakhan has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine, Fern Health, Lin Health. Dr. Lakhan has received personal compensation in the range of $500,000-$999,999 for serving as an officer or member of the Board of Directors for Click Therapeutics, SpineThera. Dr. Lakhan has stock in Zogenix, NeuroSport, Click Therapeutics, SpineThera.
Saad Abdul Sami Mir, MD Dr. Mir has nothing to disclose.
Kunal V. Desai, MD Dr. Desai has nothing to disclose.
Edrich Joseph Rodrigues, MBBChB The institution of Dr. Rodrigues has received research support from Australian Brain Foundation.
Channa Adithya Hewamadduma, PhD, MBBS, FRCP, FRC Dr. Hewamadduma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Hewamadduma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ARENX. Dr. Hewamadduma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIOGEN. Dr. Hewamadduma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE. The institution of Dr. Hewamadduma has received research support from Neurocare . The institution of Dr. Hewamadduma has received research support from Sheffield Charitable Trust. Dr. Hewamadduma has received personal compensation in the range of $5,000-$9,999 for serving as a Adult Expert with National Health Service England (NHSE).
Jai *use 131043 Perumal No disclosure on file
Jennifer Ann O'Malley, MD, PhD Dr. O'Malley has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for PTC Therapeutics. Dr. O'Malley has stock in Doximity. The institution of Dr. O'Malley has received research support from Grace Sciences.
Joseph Duffy The institution of Joseph Duffy has received research support from NIH. Joseph Duffy has received publishing royalties from a publication relating to health care.
Loretta Norton Loretta Norton has nothing to disclose.
Angela C. Russell, MD Dr. Russell has nothing to disclose.
Martina Absinta, MD Dr. Absinta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Absinta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abata Therapeutics. The institution of Dr. Absinta has received research support from International MS Alliance. The institution of Dr. Absinta has received research support from FRRB Early Career Award. The institution of Dr. Absinta has received research support from Cariplo Foundation.
Allison Little, PharmD Dr. Little has received personal compensation for serving as an employee of UCB.
Neal S. Parikh, MD Dr. Parikh has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for cases of neurological illness. The institution of Dr. Parikh has received research support from Leon Levy Foundation. The institution of Dr. Parikh has received research support from Florence Gould Foundation. The institution of Dr. Parikh has received research support from NY State Empire Clinical Research Investigator Program. The institution of Dr. Parikh has received research support from NIA. The institution of Dr. Parikh has received research support from Medtronic.
Yasir Pervaiz Khan, MD No disclosure on file
Jennifer Harris, MD Dr. Harris has nothing to disclose.
Vijayakumar Javalkar, MD, FAAN Dr. Javalkar has nothing to disclose.
Sameer Sharma, MD, MBBS Dr. Sharma has nothing to disclose.
Joel N. Phillips, DO Dr. Phillips has nothing to disclose.
Divyanshu Dubey, MD, FAAN The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Dubey has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Moffit Cancer Center . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care.
Michael Jonathan Star, MD Dr. Star has nothing to disclose.
Elisheva Ruth Coleman, MD Dr. Coleman has nothing to disclose.
Jennifer Victoria Robblee, MD Dr. Robblee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Impel. Dr. Robblee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Robblee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tonix. An immediate family member of Dr. Robblee has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Scottsdale Providence. The institution of Dr. Robblee has received research support from Eli Lilly. The institution of Dr. Robblee has received research support from AbbVie. The institution of Dr. Robblee has received research support from Barrow Neurological Institute. Dr. Robblee has received publishing royalties from a publication relating to health care. Dr. Robblee has received publishing royalties from a publication relating to health care.
Anza Memon, MD, FAAN Dr. Memon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutic .
Richa Sharma, MD Dr. Sharma has received research support from NIH. Dr. Sharma has received intellectual property interests from a discovery or technology relating to health care.
Ulrike Kaunzner, MD Dr. Kaunzner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Kaunzner has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medlearning.
Rachel Forman, MD Dr. Forman has nothing to disclose.
Michele Cavallari, MD The institution of Dr. Cavallari has received research support from BrightFocus Foundation. The institution of Dr. Cavallari has received research support from Brigham Research Institute. The institution of Dr. Cavallari has received research support from Department of Radiology at Brigham and Women's Hospital. The institution of Dr. Cavallari has received research support from Hebrew SeniorLife Rehabilitation Center. Dr. Cavallari has received intellectual property interests from a discovery or technology relating to health care.
Mouna Aissi Mouna Aissi has nothing to disclose.
Jeremy J. Laukka, PhD Dr. Laukka has nothing to disclose.
Rakesh Jain Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie (Allergan). Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Adamas. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alfasigma. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alkermes. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Axsome. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boehringer Ingleheim. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Corium. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Evidera. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Impel. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. An immediate family member of Rakesh Jain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neos Therapeutics. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine Biosciences. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Osmotica. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Otsuka. An immediate family member of Rakesh Jain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Otsuka. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pamlab. An immediate family member of Rakesh Jain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pamlab. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sage Therapeutics. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Shire. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. An immediate family member of Rakesh Jain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Transcend Therapeutics. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie (Allergan). Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alkermes. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Axsome. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Corium. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Indivior. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Intra-Cellular Therapies. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Ironshore. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. An immediate family member of Rakesh Jain has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lilly. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merck. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neos Therapeutics. Rakesh Jain has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Neurocrine Biosciences. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Otsuka. An immediate family member of Rakesh Jain has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Otsuka. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Pamlab. An immediate family member of Rakesh Jain has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pamlab. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Pfizer. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Shire. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion. An immediate family member of Rakesh Jain has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Takeda. Rakesh Jain has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Teva. Rakesh Jain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Tris Pharmaceuticals. Rakesh Jain has received research support from AbbVie (Allergan). Rakesh Jain has received research support from Lilly. Rakesh Jain has received research support from Lundbeck. Rakesh Jain has received research support from Otsuka. Rakesh Jain has received research support from Pfizer. Rakesh Jain has received research support from Shire. Rakesh Jain has received research support from Takeda.
Anthony M. Bradshaw, MD Dr. Bradshaw has nothing to disclose.
Virginia Baker, MD Dr. Baker has nothing to disclose.
Shahin Khayambashi, MD Dr. Khayambashi has nothing to disclose.
Ravi Garg, MD Dr. Garg has nothing to disclose.
Fernando Maestu Fernando Maestu has nothing to disclose.
Max M. Klein, PhD The institution of Max M. Klein, PhD has received research support from NIH.
Todd Grinnell, PhD Todd Grinnell, PhD has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc..
Nadeem I. Khan, MD Dr. Khan has nothing to disclose.
Bhaskar Roy, MD Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda Pharmaceuticals. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Roy has stock in Cabaletta bio. . The institution of Dr. Roy has received research support from Martin Shubik Fund for IBM at Yale University. The institution of Dr. Roy has received research support from Abcuro Pharmaceuticals.
Jaclyn Martindale, DO Dr. Martindale has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorder Society. The institution of Dr. Martindale has received research support from Tourette Association of America. The institution of Dr. Martindale has received research support from American Board of Neurology and Psychiatry.
Jessica E. Rexach, MD, PhD Dr. Rexach has nothing to disclose.
Sabreena J. Slavin, MD Dr. Slavin has nothing to disclose.
Pratit Dhirajlal Patel, MD Dr. Patel has nothing to disclose.
Michelle P. Lin, MD Dr. Lin has nothing to disclose.
Young-Min Kim, MD Dr. Kim has nothing to disclose.
Ashhar Ali, DO, FAAN Dr. Ali has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Ebsco.
Rick R. Gill, MD Dr. Gill has nothing to disclose.
Charlene Jennifer Ong, MD Dr. Ong has nothing to disclose.
Eliza Cushman Miller, MD Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for medical malpractice cases. The institution of Dr. Miller has received research support from National Institutes of Health. Dr. Miller has a non-compensated relationship as a member of ASA Advisory Council with American Heart Association/American Stroke Association that is relevant to AAN interests or activities.
Davide Martino, MD, PhD Dr. Martino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Martino has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merz Pharma Canada Ltd..
Omar Samad, PhD Dr. Samad has received personal compensation for serving as an employee of Eisai.
Mahima Kapoor, MD The institution of Dr. Kapoor has received research support from Bethlehem Griffiths Research Foundation .
Bertrand Paul Tseng, MD, PhD Dr. Tseng has nothing to disclose.
Adrian Owen No disclosure on file
Ahmed Toosy The institution of Ahmed Toosy has received research support from Rosetrees Trust.
Ankit Pahwa Ankit Pahwa has nothing to disclose.
Brian Kopell Brian Kopell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Brian Kopell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbott Neuromodulation. Brian Kopell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Enspire DBS.
Donna Roberts Donna Roberts has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guerbet. Donna Roberts has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Guerbet. The institution of Donna Roberts has received research support from Guerbet. The institution of Donna Roberts has received research support from NASA.
Edoardo G. Spinelli, MD Dr. Spinelli has nothing to disclose.
Eva Mistry No disclosure on file
Helena Gama Helena Gama has received personal compensation for serving as an employee of Bial-Portela & Cª S.A..
Hongxin Chen Hongxin Chen has nothing to disclose.
Marios Yiannakas Marios Yiannakas has nothing to disclose.
Michael Ahmadi No disclosure on file
Nicholas Thompson Nicholas Thompson has nothing to disclose.
Prasanna Venkatesan Eswaradass, MD Dr. Eswaradass has nothing to disclose.
Richard Reilly, PhD Dr. Reilly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for La Caixa Foundation. Dr. Reilly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for La Caixa Foundation, Barcelona, Spain. The institution of Dr. Reilly has received research support from Enterprise Ireland. The institution of Dr. Reilly has received research support from Science Foundation Ireland. The institution of Dr. Reilly has received research support from Health Research Board.
Robert Roth Robert Roth has received publishing royalties from a publication relating to health care.
Thanh Nguyen Thanh Nguyen has nothing to disclose.
Daniel Garbin Di Luca, MD Dr. Garbin Di Luca has nothing to disclose.
Nadia McMillan, MD, PhD Dr. McMillan has nothing to disclose.
Tamara Hoyt Ms. Hoyt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono.
Nolan Campbell Nolan Campbell has received personal compensation for serving as an employee of Biogen. Nolan Campbell has stock in Biogen.
Cedric Laloyaux, PhD Dr. Laloyaux has received personal compensation for serving as an employee of UCB.
Ning Su, MD Dr. Su has nothing to disclose.
Lixin Zhou Lixin Zhou has nothing to disclose.
Vijay K. Ramanan, MD, PhD The institution of Dr. Ramanan has received research support from the National Institutes of Health. The institution of Dr. Ramanan has received research support from the Mangurian Foundation for Lewy Body Disease Research. The institution of Dr. Ramanan has received research support from as part of clinical trials sponsored by the Alzheimer's Association, Eisai, the Alzheimer's Treatment and Research Institute at USC, and Transposon Therapeutics, Inc.. The institution of Dr. Ramanan has received research support from Medscape. Dr. Ramanan has received personal compensation in the range of $500-$4,999 for serving as a Conference Speaker/Organizer (Honoraria) with AANI.
Mohammad Abdurrehman Sheikh, MBBS Dr. Sheikh has nothing to disclose.
Ranier G. Reyes, MD Dr. Reyes has nothing to disclose.
Nabil Wees, MD Dr. Wees has nothing to disclose.
Abbas Kharal, MD Dr. Kharal has nothing to disclose.
Jesse Thon, MD An immediate family member of Dr. Thon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. An immediate family member of Dr. Thon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. An immediate family member of Dr. Thon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech.
Christian J. Camargo, MD Dr. Camargo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Camargo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GE Health. The institution of Dr. Camargo has received research support from American Academy of Neurology.
Catherine Hassett, MD Dr. Hassett has nothing to disclose.
Sami Alkasab, MD No disclosure on file
Nara Michaelson, MD The institution of Dr. Michaelson has received research support from Biogen. The institution of Dr. Michaelson has received research support from the National Multiple Sclerosis Society (NMSS).
Jason Singh Gill, MD, PhD Dr. Gill has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Elite Medical Experts. The institution of Dr. Gill has received research support from NIH-NINDS.
Adeel Zubair, MD Dr. Zubair has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The MedNet.
Sonja Stutzman Sonja Stutzman, 10738 has received publishing royalties from a publication relating to health care.
Shokufeh Sadaghiani Shokufeh Sadaghiani, 1129 has nothing to disclose.
Anna Patten Anna Patten, 14934 has received personal compensation for serving as an employee of Eisai Ltd.
Atul T. Patel Atul T. Patel, 15908 has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Revance. Atul T. Patel, 15908 has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Atul T. Patel, 15908 has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Atul T. Patel, 15908 has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/Abbvie. Atul T. Patel, 15908 has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for IPSEN. The institution of Atul T. Patel, 15908 has received research support from Allergan. The institution of Atul T. Patel, 15908 has received research support from Revance. The institution of Atul T. Patel, 15908 has received research support from IPSEN.
Zhi Sheng Zhi Sheng, 1800 has nothing to disclose.
C Eswaradass C Eswaradass, 303 has nothing to disclose.
Cris M. Ida Cris M. Ida, 4790 has nothing to disclose.
Sabahattin Saip Sabahattin Saip, 6729 has nothing to disclose.
Ferran Padros Ferran Padros, 8186 has nothing to disclose.
Mindl M. Weingarten, PharmD Dr. Weingarten has received personal compensation for serving as an employee of SK Life Science.
Mariel Yvonne Pullman, MD The institution of Dr. Pullman has received research support from Empire Clinical Research Investigator Program.
Annemie Ribbens Annemie Ribbens, 9599 has received personal compensation for serving as an employee of icometrix. Annemie Ribbens, 9599 has stock in icometrix.
Fatma Yesim Parman, MD Dr. Parman has nothing to disclose.
Erik Middlebrooks Erik Middlebrooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Varian Medical Systems Inc. Erik Middlebrooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific Corp. The institution of Erik Middlebrooks has received research support from Varian Medical Systems Inc.
Angelene Christensen Ms. Christensen has a non-compensated relationship as a project manager with InterPro Bioscience that is relevant to AAN interests or activities.
Robert Vann, PhD Dr. Vann has received personal compensation for serving as an employee of Impel Neuropharma. Dr. Vann has received personal compensation for serving as an employee of Biogen.
David Cantu, PhD Dr. Cantu has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc..
Sebastiano Galantucci Mr. Galantucci has nothing to disclose.
Janneke Van Wingerden Janneke Van Wingerden has received personal compensation for serving as an employee of Sanofi Genzyme.
Veronica Popescu, MD, PhD The institution of Dr. Popescu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme. The institution of Dr. Popescu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Almirall. The institution of Dr. Popescu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Popescu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Dr. Popescu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Popescu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. The institution of Dr. Popescu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Popescu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Dr. Popescu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. The institution of Dr. Popescu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Popescu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Popescu has received research support from FWO.
Ka-Ho Wong The institution of Mr. Wong has received research support from The Sumaira Foundation .
Melissa Mariscal, MD Dr. Mariscal has nothing to disclose.
Tamra Ishan Jayendra Ranasinghe, MD Dr. Ranasinghe has nothing to disclose.
Robert Stanton, II, MD The institution of Dr. Stanton has received research support from NIH.
Elizabeth Matthews, MD Dr. Matthews has nothing to disclose.
Isaiah Kletenik, MD The institution of Dr. Kletenik has received research support from NIH.
David Robinson, MD The institution of Dr. Robinson has received research support from NIH. The institution of Dr. Robinson has received research support from UC.
Silvia Basaia Silvia Basaia has nothing to disclose.
Carlos Andres Cevallos, MD Dr. Cevallos has nothing to disclose.
Heather Clark Heather Clark has received personal compensation for serving as an employee of Mayo Clinic. The institution of Heather Clark has received research support from NIH. Heather Clark has received publishing royalties from a publication relating to health care.
Hugo Cuellar-Saenz Hugo Cuellar-Saenz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Microvention.
Jenny Davies An immediate family member of Jenny Davies has received personal compensation for serving as an employee of IBM. An immediate family member of Jenny Davies has stock in IBM. An immediate family member of Jenny Davies has stock in Kyndryl.
Sami Elmoufti Sami Elmoufti has nothing to disclose.
Lilly Fagatele Ms. fagatele has nothing to disclose.
Robert Fahed Robert Fahed has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Stryker Neurovascular. Robert Fahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Yocan Medical Systems.
Elayne Feld Elayne Feld has nothing to disclose.
Ethan Hollingsworth Ethan Hollingsworth has nothing to disclose.
Rob McMurray Rob McMurray has received personal compensation for serving as an employee of Eisai Europe ltd.
Leslie Lundt Leslie Lundt has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc.
Marcus Sucksdorff, MD Dr. Sucksdorff has nothing to disclose.
Lucas Alessandro, Sr., MD Dr. Alessandro has nothing to disclose.
Sara Collorone The institution of Sara Collorone has received research support from Rosetreest Trust. The institution of Sara Collorone has received research support from MAGNIMS/ECTRIMS.
Arie Gafson, MD, PhD Dr. Gafson has stock in Biogen.
Cortnee Roman, NP Ms. Roman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Ms. Roman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Ms. Roman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Ms. Roman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Ms. Roman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Ms. Roman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Ms. Roman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Ms. Roman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myer Squibb. Ms. Roman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Ms. Roman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Ms. Roman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Ms. Roman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genzyme. Ms. Roman has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Ms. Roman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myer Squibb/Celgene.
Sutapa Ray, PhD Dr. Ray has received personal compensation for serving as an employee of Impel Pharmaceuticals. Dr. Ray has stock in Impel Pharmaceuticals.
Catherine Daniela Chong, PhD, FAAN Dr. Chong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for HCOP. The institution of Dr. Chong has received research support from AMGEN. The institution of Dr. Chong has received research support from Department of Defense. The institution of Dr. Chong has received research support from NIH. An immediate family member of Dr. Chong has received intellectual property interests from a discovery or technology relating to health care.
Kitti Thiankhaw, MD Dr. Thiankhaw has nothing to disclose.
Roman Rubio Roman Rubio has received personal compensation for serving as an employee of Revance.
Wenwen Zhang, MD, PhD Dr. Zhang has nothing to disclose.
Madeleine Klein, BS The institution of an immediate family member of Madeleine Klein has received research support from NIH.
Joshua Battley, MD Dr. Battley has nothing to disclose.
Samantha Roman, MD Dr. Roman has nothing to disclose.
Yasmin Aghajan, MD Dr. Aghajan has nothing to disclose.
Davis Leon Ewbank, DO Dr. Ewbank has nothing to disclose.
Stephanie Lyden, MD Dr. Lyden has nothing to disclose.
Jyotika Singh Ms. Singh has nothing to disclose.
Xenos Mason, MD Dr. Mason has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Mason has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbott Labs. Dr. Mason has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific.
Malgorzata Miller, MD Dr. Miller has nothing to disclose.
Andersen Shemme, MD Dr. Shemme has nothing to disclose.
Anisha Garg, MD Dr. Garg has nothing to disclose.
Ylec Mariana Cardenas Castillo, MD Dr. Cardenas Castillo has nothing to disclose.
Kendra K. Davis Ms. Davis has nothing to disclose.
Markus Hannan, MD Dr. Hannan has nothing to disclose.
Maria Gabriela Martucci, MD Dr. Martucci has nothing to disclose.
Adrian Isidoro Espiritu, MD Dr. Espiritu has nothing to disclose.
Tracy J. Koehler Tracy J. Koehler has nothing to disclose.
Gina Dumkrieger, PhD Gina Dumkrieger has received personal compensation for serving as an employee of Mayo Clinic. The institution of Gina Dumkrieger has received research support from NIH. The institution of Gina Dumkrieger has received research support from DOD. The institution of Gina Dumkrieger has received research support from AMGEN.
Camilo Bermudez, MD, PhD Dr. Bermudez has nothing to disclose.
John J. Chen John J. Chen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. John J. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. John J. Chen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon.
Khody Farahmand Khody Farahmand has received personal compensation for serving as an employee of Neurocrine Biosciences . Khody Farahmand has stock in Neurocrine.
Alexandra Boubour Ms. Boubour has received research support from The Fulbright Program.
Feng Tian No disclosure on file
Fedor Panov Fedor Panov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for neuropace. Fedor Panov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for zimmer biomet.
Adam Strzelczyk Adam Strzelczyk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Angelini Pharma. Adam Strzelczyk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Desitin Arzneitmittel. Adam Strzelczyk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Adam Strzelczyk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Marinus. Adam Strzelczyk has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GW/Jazz pharmaceuticals. Adam Strzelczyk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UNEEG. Adam Strzelczyk has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB Pharma (Zogenix). Adam Strzelczyk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Adam Strzelczyk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bicodex.
Christopher A. Brown, MD, PhD The institution of Dr. Brown has received research support from National Institute of Health.
Christoph Correll Christoph Correll has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Christoph Correll has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Christoph Correll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alkermes. Christoph Correll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Christoph Correll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Angelini. Christoph Correll has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axsome. Christoph Correll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cardio Diagnostics. Christoph Correll has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerevel. Christoph Correll has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Compass Pathways. Christoph Correll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Gedeon Richter. Christoph Correll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Holmusk. Christoph Correll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IntraCellular Therapies. Christoph Correll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Karuna. Christoph Correll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LB Pharma. Christoph Correll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Christoph Correll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MedInCell. Christoph Correll has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Christoph Correll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mindpax. Christoph Correll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mylan. Christoph Correll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine. Christoph Correll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Noven. Christoph Correll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Otsuka. Christoph Correll has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Christoph Correll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Recordati. Christoph Correll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROVI. Christoph Correll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Seqirus. Christoph Correll has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Life Science. Christoph Correll has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sumitomo Dainippon. Christoph Correll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sunovion. Christoph Correll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Christoph Correll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris. Christoph Correll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen/Johnson & Johnson. Christoph Correll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Christoph Correll has received research support from Janssen/Johnson & Johnson. Christoph Correll has received research support from Takeda.
Ayse Candayan Ayse Candayan has nothing to disclose.
Elizabeth Fisher Elizabeth Fisher has received personal compensation for serving as an employee of Biogen. Elizabeth Fisher has stock in Biogen. Elizabeth Fisher has received intellectual property interests from a discovery or technology relating to health care.
Javier Salas-Puig Javier Salas-Puig has nothing to disclose.
Joseph Sullivan Joseph Sullivan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epygenix. Joseph Sullivan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. The institution of Joseph Sullivan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Encoded Therapetucis. Joseph Sullivan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Invitate. Joseph Sullivan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Longboard. Joseph Sullivan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwigh Biosciences. Joseph Sullivan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Knopp Biosciences. Joseph Sullivan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Asceneuron. Joseph Sullivan has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various Law Firms. Joseph Sullivan has received stock or an ownership interest from Epygenix Therapeutics. The institution of Joseph Sullivan has received research support from Zogenix. The institution of Joseph Sullivan has received research support from Marinus Pharmaceuticals. The institution of Joseph Sullivan has received research support from Stoke Therapeutics. The institution of Joseph Sullivan has received research support from Encoded Therapeutics. The institution of Joseph Sullivan has received research support from BioPharm solutions.
Thibo Billiet Thibo Billiet has received personal compensation for serving as an employee of icometrix.
Fei Han No disclosure on file
Jun Ni Jun Ni has nothing to disclose.
Ming Yao No disclosure on file
Muhammad Ismail Khalid Yousaf, MD Dr. Yousaf has nothing to disclose.
Sydni Cole, MD Dr. Cole has nothing to disclose.
Melanie Marcille Ms. Marcille has nothing to disclose.
Miklos Palotai Miklos Palotai has nothing to disclose.
Balakrishnan Ramasamy, MD, MBBS Dr. Ramasamy has nothing to disclose.
Shikha Polega Shikha Polega has received personal compensation for serving as an employee of UCB. Shikha Polega has stock in UCB. Shikha Polega has stock in Zogenix.
Peter Isquith Peter Isquith has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Global Pharma Consultancy, LLC. Peter Isquith has received publishing royalties from a publication relating to health care.
Rene Utianski The institution of Rene Utianski has received research support from NIH.
Robert Joseph Cruz Sarmiento, MD Dr. Sarmiento has nothing to disclose.
Sadaf Saba Sadaf Saba has nothing to disclose.
Shan Siddiqi, MD Dr. Siddiqi has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Magnus Medical. Dr. Siddiqi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Brainsway Ltd. Dr. Siddiqi has stock in Brainsway Ltd. Dr. Siddiqi has stock in Magnus Medical. Dr. Siddiqi has received intellectual property interests from a discovery or technology relating to health care.
Arvin Parvathaneni, MD Dr. Parvathaneni has nothing to disclose.
Bahadar Singh Srichawla, DO, MS Dr. Srichawla has nothing to disclose.
Alexander Sandweiss, MD, PhD Dr. Sandweiss has nothing to disclose.
Rebecca Jeannette Levy, MD Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tome.
Jane Khalife, MD Dr. Khalife has nothing to disclose.
Sydney Vivanco Mrs. Vivanco has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Mrs. Vivanco has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Mrs. Vivanco has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Mrs. Vivanco has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Mrs. Vivanco has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
Sviatoslav Redko, MD Dr. Redko has nothing to disclose.
Evan Kolesnick, DO Mr. Kolesnick has nothing to disclose.
Emily Maly, MD Dr. Maly has nothing to disclose.
Ayush Chandra Mr. Chandra has nothing to disclose.
Lilly Chen Lilly Chen has received personal compensation for serving as an employee of Boston Scientific .
Carl Froilan Leochico No disclosure on file
Laurel *use 388309 Packard Laurel Packard has nothing to disclose.
Peter Martin Mr. Martin has nothing to disclose.
Stéphane Auvin No disclosure on file
Colm Elliott Colm Elliott has received personal compensation for serving as an employee of NeuroRx Research.
Avash Das Avash Das has nothing to disclose.
Steven Petrou Steven Petrou has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Praxis Precision Medicines. Steven Petrou has stock in Praxis Precision Medicines. The institution of Steven Petrou has received research support from Praxis Precision Medicines. The institution of Steven Petrou has received research support from Medical Research Future Fund. Steven Petrou has received intellectual property interests from a discovery or technology relating to health care. Steven Petrou has received intellectual property interests from a discovery or technology relating to health care.
Emily Dennis The institution of Ms. Dennis has received research support from NIH.
Paula Schiapparelli Paula Schiapparelli has nothing to disclose.
Alfredo Quinones-Hinojosa No disclosure on file
Neda Jahanshad The institution of Neda Jahanshad has received research support from Biogen Inc.
Andrew Cutler Andrew Cutler has received personal compensation for serving as an employee of Neuroscience Education Institute. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alfasigma. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alkermes. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intra-Cellular Therapies. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Andrew Cutler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for MedAvante-ProPhase. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Noven. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Otsuka. Andrew Cutler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sage Therapeutics. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion. Andrew Cutler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Andrew Cutler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioXcel. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Corium. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Karuna. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neumora. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Relmada. Andrew Cutler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Andrew Cutler has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for COMPASS Pathways. Andrew Cutler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AbbVie. Andrew Cutler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alkermes. Andrew Cutler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Intra-Cellular Therapies. Andrew Cutler has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Ironshore. Andrew Cutler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Andrew Cutler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurocrine. Andrew Cutler has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Noven. Andrew Cutler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Otsuka. Andrew Cutler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion. Andrew Cutler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Andrew Cutler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Teva. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Axsome. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BioXcel. Andrew Cutler has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Corium. Andrew Cutler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Andrew Cutler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Tris. Andrew Cutler has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Neuroscience Education Institute.
William A. Vandergrift William A. Vandergrift has nothing to disclose.
Mariem Mhiri Mariem Mhiri has nothing to disclose.
Nimer Abushehab No disclosure on file
Tyler Alexander Gumpel Tyler Gumpel has nothing to disclose.
Tikku George, MD Dr. George has nothing to disclose.
Javier Lenin Galvan Mr. Galvan has stock in Pfizer Inc. Mr. Galvan has stock in Butterfly Network Inc. Mr. Galvan has stock in Gilead Sciences Inc. Mr. Galvan has stock in Hyperfine Inc. Mr. Galvan has stock in MIrati Therapeutics Inc.
Zarmina Mufti, MD Dr. Mufti has nothing to disclose.
Mark Joshua Rosenberg, MD Dr. Rosenberg has nothing to disclose.
Anne-Liv Schulz Anne-Liv Schulz has received personal compensation for serving as an employee of UCB. Anne-Liv Schulz has received stock or an ownership interest from UCB.
John R. Mills, MD, PhD Dr. Mills has received intellectual property interests from a discovery or technology relating to health care.
Sung Chul Lim Sung Chul Lim has nothing to disclose.
Andre Granger, MD, MBA Dr. Granger has nothing to disclose.
Louis Ferrari Louis Ferrari has received personal compensation for serving as an employee of SK Life science.
Chandra Sekhar Mannyam, MBBS Dr. Mannyam has nothing to disclose.
Mar Tintore The institution of Mar Tintore has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Mar Tintore has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Mar Tintore has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Mar Tintore has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche . The institution of Mar Tintore has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme . The institution of Mar Tintore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Mar Tintore has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela bio. The institution of Mar Tintore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Mar Tintore has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Mar Tintore has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Mar Tintore has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Mar Tintore has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . The institution of Mar Tintore has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. The institution of Mar Tintore has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parexel and UCB Biopharma. Mar Tintore has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Multiple Sclerosis Journal: Experimental, Translational and Clinical. The institution of Mar Tintore has received research support from Fundació La Marató de TV3. The institution of Mar Tintore has received research support from Instituto de Salud Carlos III. The institution of Mar Tintore has received research support from Instituto de Salud Carlos III.
Melih Tutuncu, MD Melih Tutuncu has nothing to disclose.
Shahar Shelly, MD Dr. Shelly has nothing to disclose.
Shameer Rafee, MBBS Dr. Rafee has nothing to disclose.
Takamichi Yamamoto, MD, PhD, FAES Dr. Yamamoto has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai. Dr. Yamamoto has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Daiichi-Sankyo.
Carmen Vizzino Carmen Vizzino has nothing to disclose.
Kelley Dalby Kelley Dalby has received personal compensation for serving as an employee of Praxis Precision Medicines. Kelley Dalby has stock in Praxis Precision Medicines. Kelley Dalby has stock in RogCon.
Matthew Hart, MD Dr. Hart has nothing to disclose.
Zachary Pardieck, MD Dr. Pardieck has nothing to disclose.
Rahul Chandra, MD Dr. Chandra has nothing to disclose.
Asad Ahrar, MD Dr. Ahrar has nothing to disclose.
Philip Michael McCarthy, DO Dr. McCarthy has nothing to disclose.
Kenneth Riley Dalton, III, MD Dr. Dalton has nothing to disclose.
Renato Oliveira, MD Dr. Oliveira has nothing to disclose.
Victor Bushlyar, MD Dr. Bushlyar has nothing to disclose.
Victoria Michelle Rice, DO Dr. Rice has nothing to disclose.
Nadia Khalil, MD Dr. Khalil has received personal compensation in the range of $0-$499 for serving as a Resident and Fellow Council Member with American Association of Neuromuscular & Electrodiagnostic Medicine. Dr. Khalil has received personal compensation in the range of $0-$499 for serving as a MS Mentorship Forum Participant with Foundation of the Consortium of Multiple Sclerosis Centers.
William Joseph Therriault Mr. Therriault has nothing to disclose.
Rachel Elizabeth Triay, MD Dr. Triay has nothing to disclose.
Sudipto Dolui, PhD Dr. Dolui has nothing to disclose.
Arman Cakar Arman Cakar has nothing to disclose.
Veronica Castelnovo, MSc Dr. Castelnovo has nothing to disclose.
Heather Downs Mrs. Downs has nothing to disclose.
Bade Gulec Bade Gulec has nothing to disclose.
Darshan Mehta Darshan Mehta has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc. .
Jean-Pierre Lindenmayer The institution of Jean-Pierre Lindenmayer has received research support from Roche. The institution of Jean-Pierre Lindenmayer has received research support from Neurocrine. The institution of Jean-Pierre Lindenmayer has received research support from GW.
Kyle Walsh No disclosure on file
Michela Leocadi, MSc Dr. Leocadi has nothing to disclose.
Carmen Tur No disclosure on file
Andrew Schuster Andrew Schuster has nothing to disclose.
Iryna Leunikava Iryna Leunikava has nothing to disclose.
Yuehui Hong Ms. Hong has nothing to disclose.
Felix Rosenow Felix Rosenow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Felix Rosenow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arvelle. Felix Rosenow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharmaceuticals. Felix Rosenow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Felix Rosenow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EISAI. Felix Rosenow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GW Pharmaceuticals. The institution of Felix Rosenow has received research support from EISAI. Felix Rosenow has received publishing royalties from a publication relating to health care.
Maria Agustina Ruiz Yanzi, MD Dr. Ruiz Yanzi has nothing to disclose.
Mario Emiliano Ricciardi, Sr., MD Dr. Ricciardi has nothing to disclose.
Markus Matilainen Markus Matilainen has nothing to disclose.
Marjo Nylund Ms. Nylund has received research support from The Finnish MS Foundation. Ms. Nylund has received research support from Maire Taponen Foundation. Ms. Nylund has received research support from The Finnish Cultural Foundation.
Nikolai Gil Diwa Reyes, MD Dr. Reyes has nothing to disclose.
Camilla Cividini, MSc Ms. Cividini has nothing to disclose.
Luisa Alejandra Diaz-Arias, MD Dr. Diaz-Arias has nothing to disclose.
Maria Alejandra Garcia-Dominguez, MD Dr. Garcia-Dominguez has nothing to disclose.
Gilbert J. L'Italien Gilbert J. L'Italien has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Gilbert J. L'Italien has stock in biohaven pharmaceuticals.
Tricia Tubergen Tricia Tubergen has received personal compensation in the range of $0-$499 for serving as a Consultant for Medtronic.
Katharine Dermigny, MD Dr. Dermigny has nothing to disclose.
Eduardo Dunayevich Eduardo Dunayevich has received personal compensation for serving as an employee of Neurocrine Biosciences. Eduardo Dunayevich has stock in Neurocrine Biosciences.
Mahesh Pundlik Kate, MD Dr. Kate has nothing to disclose.
Jeffrey Kuerbitz, PhD Dr. Kuerbitz has nothing to disclose.
Cynthia Grossman Cynthia Grossman has received personal compensation for serving as an employee of Biogen. Cynthia Grossman has stock in Biogen .
Daniel P. Bradley Daniel Bradley has nothing to disclose.
Linda Harris, MPH Ms. Harris has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Ms. Harris has received stock or an ownership interest from Biohaven Pharmaceuticals.
Kelli Money, MD, PhD Dr. Money has nothing to disclose.
Junaid Ansari, MD Dr. Ansari has nothing to disclose.
Amir Neshatfar, MD Dr. Neshatfar has nothing to disclose.
Maithreyi Chappidi, MD Dr. Chappidi has nothing to disclose.
Alyssa Marie Smith, MD Dr. Smith has nothing to disclose.
Andrew Dugue, MD Dr. Dugue has nothing to disclose.
Kimberly O'Neill, MD Dr. O'Neill has nothing to disclose.
Joyce Mbiziwo-Tiapo, MD Dr. Mbiziwo-Tiapo has nothing to disclose.
Barbara Basil, MD Dr. Basil has nothing to disclose.
Purva Choudhari, MD Dr. Choudhari has nothing to disclose.
Jocelyn Bailosis Lorenzo, MD Dr. Lorenzo has nothing to disclose.
Sally Ladsaria, MD Dr. Ladsaria has nothing to disclose.
Ashley Raedy, MD Dr. Raedy has nothing to disclose.
Sanem Pinar Uysal, MD Dr. Uysal has nothing to disclose.
Ai Aileen Ohno, MD Dr. Ohno has nothing to disclose.
Sarah Syed Zaheer, MD Dr. Zaheer has nothing to disclose.
Tatum Moog Miss Moog has nothing to disclose.
Alma Ghirelli Miss Ghirelli has nothing to disclose.
Eoghan Donlon, MBBS Dr. Donlon has nothing to disclose.
Odei Alayyas, MD Dr. Alayyas has nothing to disclose.
Dhara Mehta, DO Dr. Mehta has nothing to disclose.
Svend Geertsen, PhD Dr. Geertsen has received personal compensation for serving as an employee of Sanofi.
Mohammad Ravi Ghani, MD Dr. Ghani has nothing to disclose.
Zsolt Laszlo Illes Zsolt Laszlo Illes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Zsolt Laszlo Illes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Zsolt Laszlo Illes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Zsolt Laszlo Illes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Zsolt Laszlo Illes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Zsolt Laszlo Illes has received research support from Danish Research Council.
Daniel R. Thomases, PhD Dr. Thomases has received personal compensation for serving as an employee of Sunovion Pharmaceuticals.
Laura Taraboanta Laura Taraboanta has received personal compensation for serving as an employee of Click Therapeutics. Laura Taraboanta has stock in Click Therapeutics.
Sandra Badial Ms. Badial has nothing to disclose.
Melissa Hernández Vega, MD Dr. Vega has nothing to disclose.
Hayley Gibler Williams, MD An immediate family member of Dr. Williams has stock in Jazz Pharmaceuticals.
Julyana Medeiros Dantas, MD Dr. Dantas has nothing to disclose.
Holly Sim, MD Dr. Sim has nothing to disclose.
Ping Shi, MD Dr. Shi has nothing to disclose.
Jonathan William Handshoe, MD Dr. Handshoe has nothing to disclose.
Xue Yang, MD, PhD Dr. Yang has nothing to disclose.
Jenny Peih-Chir Tsai, MD Dr. Tsai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Tsai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Microvention. Dr. Tsai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Tsai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Q'Apel. Dr. Tsai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imperative Care. Dr. Tsai has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Society of NeuroInterventional Surgery.
Gerard Mullane Dr. Mullane has nothing to disclose.
Akira Machida Akira Machida has nothing to disclose.
Ian Zhang Ian Zhang has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc..
Ali Turkmani Dr. Turkmani has nothing to disclose.
Meesha Trivedi The institution of Ms. Trivedi has received research support from American Academy of Neurology.
Olga Marchesi Olga Marchesi has nothing to disclose.
Eric Jen Eric Jen has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc.
Matthew William Flounders, DO Mr. Flounders has nothing to disclose.
Nha Trang Thu Pham Nha Trang Thu Pham has received personal compensation for serving as an employee of Mayo Clinic.
Xiaotong *Use 344485 Jiang Xiaotong Jiang has nothing to disclose.
Marissa Marie Castillo Ms. Castillo has nothing to disclose.
Sara Prioni Sara Prioni has nothing to disclose.
Mahouba Frih MAHBOUBA FRIH has nothing to disclose.
Yongsheng Chen, PhD Dr. Chen has nothing to disclose.
Bastien Cyprien Caba Mr. Caba has received personal compensation for serving as an employee of Therapanacea. Mr. Caba has received personal compensation for serving as an employee of Biogen. Mr. Caba has received personal compensation in the range of $50,000-$99,999 for serving as a Research Engineer with Therapanacea. Mr. Caba has received personal compensation in the range of $100,000-$499,999 for serving as a Scientist II, ML/AI with Biogen.
Domenico Vitarella Domenico Vitarella has received personal compensation for serving as an employee of Revance.
Nowell M. Fine Nowell Fine has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of the American College of Cardiology: Case Reports. The institution of Nowell Fine has received research support from Pfizer, Akcea.
John Craig John Craig has received personal compensation in the range of $0-$499 for serving as a Consultant for Optinose USA, Inc.
Ali Mohajer, PhD Dr. Mohajer has received personal compensation for serving as an employee of Qral Group, LLC.
Scott Kamen Scott Kamen has nothing to disclose.
Maria McCormack Maria McCormack has nothing to disclose.
Sung-Chun Tang Sung-Chun Tang has nothing to disclose.
Todd Gross Todd Gross has received personal compensation for serving as an employee of Revance Therapeutics Inc. Todd Gross has stock in Revance Therapeutics Inc.
Nikos Paragios Nikos Paragios has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZeneca. Nikos Paragios has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Nikos Paragios has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for ArteDrone. Nikos Paragios has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Nikos Paragios has received intellectual property interests from a discovery or technology relating to health care. Nikos Paragios has received personal compensation in the range of $100,000-$499,999 for serving as a CEO with TheraPanacea.
Ana Pereira Ana Pereira has received personal compensation for serving as an employee of BIAL, Portela & Cª S.A..
Prashant Dongre, MD, MBBS Dr. Dongre has received personal compensation for serving as an employee of UCB Inc. Dr. Dongre has stock in UCB Inc.
Lucio Tremolizzo Lucio Tremolizzo has nothing to disclose.
Marina Creed Marina Creed has nothing to disclose.
Naga Venkatesha Murthy Pathi Jagannatham, MD Dr. Pathi Jagannatham has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Pathi Jagannatham has received personal compensation for serving as an employee of GlaxoSmithKline. Dr. Pathi Jagannatham has stock in Takeda Pharmaceuticals. Dr. Pathi Jagannatham has stock in GlaxoSmithKline.
Arturo I. Benitez, MD Dr. Benitez has received personal compensation for serving as an employee of Takeda.
Christopher J. Fitzpatrick, PhD Dr. Fitzpatrick has received personal compensation for serving as an employee of Impel Pharmaceuticals.
Bruno Padrazzi, MD Dr. Sanofi has received personal compensation for serving as an employee of Sanofi. Dr. Sanofi has received personal compensation for serving as an employee of Sanofi. Dr. Sanofi has stock in Sanofi. Dr. Sanofi has stock in Sanofi.
Omar Elsekaily, MBBS Dr. Elsekaily has nothing to disclose.
Phoebe Jiang, PhD Dr. Jiang has received personal compensation for serving as an employee of Biogen. Dr. Jiang has stock in Biogen.
Kathleen Miao Ms. Miao has nothing to disclose.
Elizabeth Evans, NP Mrs. Evans has nothing to disclose.
Anastasia Railean, MD Dr. Railean has nothing to disclose.
Kriti Bhayana, MD Dr. Bhayana has nothing to disclose.
Julia Miao Miss Miao has nothing to disclose.
Sojung Kara Park, DO Dr. Park has nothing to disclose.
Maria Barbara Grimberg, MD Dr. Grimberg has nothing to disclose.
Michael Francis Maimon Cronin The institution of Mr. Cronin has received research support from American Heart Association.
Chutithep Teekaput, MD Dr. Teekaput has nothing to disclose.
Rachel Rhinehart, PA Miss Rhinehart has nothing to disclose.
Sarah Shapiro Miss Shapiro has nothing to disclose.
Alyssa Domingue, MD Dr. Domingue has nothing to disclose.
Nuno Pedrosa De Barros, PhD Dr. De Barros has received personal compensation for serving as an employee of Icometrix.
Prabandh Reddy Buchhanolla, MBBS Dr. Buchhanolla has nothing to disclose.
Muhammad Ayub, MD Dr. Ayub has nothing to disclose.
Mustafa Jaffry Mr. Jaffry has nothing to disclose.
Nicolò Tedone, Other Dr. Tedone has nothing to disclose.
Matteo Azzimonti, MD Dr. Azzimonti has nothing to disclose.
Karnig Kazazian Mr. Kazazian has nothing to disclose.
Kazim Jaffry Mr. Jaffry has nothing to disclose.
Lillian G Matthews, PhD Dr. G Matthews has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Praxis Precision Medicines. Dr. G Matthews has stock in Praxis Precision Medicines.
Sean Stern Mr. Stern has received personal compensation for serving as an employee of SK Life Science.
Lauren A. Fowler, PhD Prof. Fowler has nothing to disclose.
Kranthi Kiran Mandava Mr. Mandava has nothing to disclose.
Florin Floricel, MD,PhD Dr. Floricel has received personal compensation for serving as an employee of UCB Biosciences GmbH. Dr. Floricel has received stock or an ownership interest from UCB Biosciences GmbH.
Pannathat Soontrapa, MD The institution of Dr. Soontrapa has received research support from Argenx.
Narjes Gouta, MD Dr. Gouta has nothing to disclose.
Rihab Ben Dhia, II Dr. Ben Dhia has nothing to disclose.
Eero Polvinen Mr. Polvinen has nothing to disclose.
Zachary Langston, Other Mr. Langston has nothing to disclose.
Neha Atulkumar Singh, PhD Dr. Singh has nothing to disclose.
Ryan Castoro, DO Dr. Castoro has nothing to disclose.
Sophia Zhou, Other Ms. Zhou has nothing to disclose.
Oscar Emanuel Garat, MD Mr. Garat has nothing to disclose.
Veronica Sendersky, Other Dr. Sendersky has received personal compensation for serving as an employee of UCB.
Amal Abbes Ms. Abbes has nothing to disclose.
Hossam Youssef Mr. Youssef has nothing to disclose.
Michelle Miranda, PhD Dr. Miranda has nothing to disclose.
Mutlu Demirer, PhD Dr. Demirer has nothing to disclose.
Michelle Murphy, PhD Dr. Murphy has nothing to disclose.
Whitney Alexandra Booker, MD Dr. Booker has nothing to disclose.
Evan Realbuto, Other Mr. Realbuto has nothing to disclose.
Ted Snyder Mr. Snyder has received personal compensation for serving as an employee of Praxis Precision Medicines. Mr. Snyder has received stock or an ownership interest from Praxis Precision Medicines.
Catherine Viscoli, PhD Ms. Viscoli has nothing to disclose.
Ayah Al-Bzour Miss Al-Bzour has nothing to disclose.
Alexandra Gaudet Ms. Gaudet has nothing to disclose.
Karen Joy Bernarte Adiao, MD Dr. Adiao has nothing to disclose.
Amanda Cyntia Lima Fonseca Rodrigues Ms. Rodrigues has nothing to disclose.
Alankar Gupta, MD Dr. Gupta has received personal compensation for serving as an employee of Click Therapeutics.
Yaman Ahmed Mr. Ahmed has nothing to disclose.
Laura Couvreur, MD Dr. Couvreur has received personal compensation in the range of $10,000-$49,999 for serving as a Intern Clinical application specialist at icometrix with The Prince Albert Fund.
Ghayda'a Netham Al-Majali Ms. Al-Majali has nothing to disclose.
Ítalo Barros Andrade Mr. Andrade has nothing to disclose.
Omri Zveik Mr. Zveik has nothing to disclose.
Abby Forrest Mrs. Forrest has nothing to disclose.
Rodolfo Manuel Roman Guzman, Sr., MD Dr. Roman Guzman has nothing to disclose.
Andreea Rawlings, PhD Dr. Rawlings has received personal compensation for serving as an employee of Sanofi. Dr. Rawlings has stock in Sanofi.
Clarence Wade Mr. Wade has nothing to disclose.
Gamaliel Aguilera Barragán Pickens, MD Dr. Aguilera Barragán Pickens has nothing to disclose.
Muhammed Ors Mr. Ors has nothing to disclose.
Ronak Uday Trivedi Mr. Trivedi has nothing to disclose.
Ying-Chi Sandy Shen, MD Dr. Shen has nothing to disclose.
Samet Cam Samet Cam has nothing to disclose.
Marc Lawrence, MD Mr. Lawrence has nothing to disclose.
Gregory Peter Devine Mr. Devine has nothing to disclose.
Karla Salazar, MD Dr. Salazar has nothing to disclose.
Christina Massrey, MD Dr. Massrey has nothing to disclose.
Douglas Aaron Wells, Jr., MD Dr. Wells has nothing to disclose.
Mary Penckofer Ms. Penckofer has nothing to disclose.
Sean K. Wang Mr. Wang has nothing to disclose.
Sophie Xie Ms. Xie has nothing to disclose.
Bryn Rubin Miss Rubin has nothing to disclose.
Galen Postma Mr. Postma has nothing to disclose.
Mouhamad Hammami Mr. Hammami has nothing to disclose.
Nihas Raja Mateti Mr. Mateti has nothing to disclose.
Ryoichi Inoue, MD Dr. Inoue has nothing to disclose.
Sama Noroozi Gilandehi, MD Dr. Noroozi Gilandehi has nothing to disclose.
Rachelle Tache, NP Mrs. Tache has nothing to disclose.
Despoina Ioannidou, PhD Dr. Ioannidou has received personal compensation for serving as an employee of Therapanacea.
Iswariya Mani, MBBS Dr. Mani has nothing to disclose.
Frederick McNulty Mr. McNulty has nothing to disclose.
Rajiv Gupta, MD,PhD Dr. Gupta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for • Idorsia, Inc. Dr. Gupta has received personal compensation in the range of $0-$499 for serving as a Consultant for Mosaic Research Management. Dr. Gupta has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Braintale Inc. Dr. Gupta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Siemens Medical Solutions, USA. Dr. Gupta has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Mary Hitchcock Memorial Hospital. The institution of Dr. Gupta has received research support from Samsung.
Cristy Savage Mrs. Savage has nothing to disclose.
Rudy Luna, MD Dr. Luna has nothing to disclose.
Sumayya Mohammed, MD Miss Mohammed has nothing to disclose.
Noora Camile Haghighi, MS Miss Haghighi has nothing to disclose.
Hajera Naveed Ms. Naveed has nothing to disclose.
Anh-Tho Antoinette Thi Nguyen Miss Nguyen has nothing to disclose.
Mehriban Sariyeva Mrs. Sariyeva has nothing to disclose.
Taylor Ariko Ms. Ariko has nothing to disclose.
Hidetaka Takeda, Sr., MD,PhD Dr. Takeda has nothing to disclose.
Artur Menegaz de Almeida Mr. Menegaz de Almeida has nothing to disclose.
Kyriakoula Varmpompiti, MBBS Dr. Varmpompiti has nothing to disclose.
Laura Ngwenya, MD,PhD The institution of Dr. Ngwenya has received research support from Abbott. The institution of Dr. Ngwenya has received research support from Biogen.
Crystal Neate, Other Ms. Neate has nothing to disclose.
Ramisha Aymon, Other Ms. Aymon has nothing to disclose.
Naomi Sara Lebowitz, Other Ms. Lebowitz has nothing to disclose.
Jane Ekhtman Ms. Ekhtman has nothing to disclose.
Rauan Kaiyrzhanov, MD Dr. Kaiyrzhanov has nothing to disclose.
Angela T.H. Kwan, MSc Miss Kwan has nothing to disclose.
Jon Bernstein, MD, PhD Dr. Bernstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CHANGE HEALTHCARE. The institution of Dr. Bernstein has received research support from NIH.
Nitsan Haham Ms. Haham has nothing to disclose.
Trieste Francis Miss Francis has nothing to disclose.
Caitlin Plovnick Ms. Plovnick has nothing to disclose.
Aarti Raj Katara Ms. Katara has nothing to disclose.
Ariel Rechtman Mr. Rechtman has nothing to disclose.
Shahar Kahila Miss Kahila has nothing to disclose.
Hejiao Mao, Other Miss Mao has nothing to disclose.
Alexander James Mills Mr. Mills has nothing to disclose.
Brendan Hare, PhD Mr. Hare has received personal compensation for serving as an employee of Click Therapeutics, Inc..
Banafsheh Shakibajahromi, MD Dr. Shakibajahromi has nothing to disclose.
Swati More Dr. More has received intellectual property interests from a discovery or technology relating to health care.
Ishah Yusaf, Other Ms. Yusaf has nothing to disclose.
Lun-Ching Chang, PhD Dr. Chang has nothing to disclose.
Katherine Wilson Timothy, Other Mrs. Timothy has nothing to disclose.
Herbert Peeples, II, Other Mr. Peeples has received personal compensation for serving as an employee of UCB.
Wencheng Zhu, Jr., Other Mr. Zhu has nothing to disclose.
Khushalee Oza Miss Oza has nothing to disclose.
Xiangmin Fan, PhD Dr. Fan has nothing to disclose.
Juanjuan Wu, Other Dr. Wu has nothing to disclose.
Victor Soto Insuga, Sr., PhD Dr. Soto Insuga has nothing to disclose.
Yasmine Saad Miss Saad has nothing to disclose.
Saba Azizi Torkanpour Miss Azizi Torkanpour has nothing to disclose.
Jacob David Baraz Mr. Baraz has nothing to disclose.
Rafaela Oliveira Marques Miss MARQUES has nothing to disclose.
Sergio Walmir de Araujo, MD Dr. Araujo has nothing to disclose.
Shin-Joe Yeh, PhD,MD Dr. Yeh has nothing to disclose.
Jiann-Shing Jeng, MD,PhD Dr. Jeng has nothing to disclose.
Indran Davagnanam, MBBS Dr. Davagnanam has nothing to disclose.
Jack F G Underwood, MBBS Dr. Underwood has received personal compensation for serving as an employee of Akrivia Health. Dr. Underwood has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for HM Courts and Tribunal Service. The institution of Dr. Underwood has received research support from the Wellcome Trust.
Paloma Soares Oliveira, Other Miss Oliveira has nothing to disclose.
Allan Dias Polverini, MD,Other Dr. Polverini has nothing to disclose.
Patricia Mendes Viana, Other Miss Viana has nothing to disclose.
Ana Carolina Toguchi, MD Miss Toguchi has nothing to disclose.
Dimitrios Bourikas Dr. Bourikas has nothing to disclose.
Frank DiFilippo, PhD The institution of Dr. DiFilippo has received research support from NIH. Dr. DiFilippo has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with American College of Radiology.
Firoza Zubeida Lussier, Other Miss Lussier has nothing to disclose.
Elelia Phillips Miss Phillips has nothing to disclose.
Lindsay Berg, Other Ms. Berg has nothing to disclose.
Zahra Azizi, MD Dr. Azizi has nothing to disclose.
Nesrine Rahmouni, Other Ms. Rahmouni has nothing to disclose.
Helen Michaela Oliveira, Other Ms. Oliveira has nothing to disclose.
Oya Zehra Uyguner, PhD Prof. UYGUNER has nothing to disclose.
Antonia Vitoria Gomes Barreiros, Other Miss Barreiros has nothing to disclose.
Acza Kalica Buarque Silva, Other Miss Silva has nothing to disclose.
Stephanie Yan Xuan Ms. Xuan has nothing to disclose.
Pulkit Khandelwal Mr. Khandelwal has nothing to disclose.
Vanessa Pallen, Other Miss Pallen has nothing to disclose.
Mohammad Taghvaei, MD Dr. Taghvaei has nothing to disclose.
Laura Beeler, Other Ms. Beeler has nothing to disclose.
Richard Dortch, PhD The institution of Dr. Dortch has received research support from NIH. The institution of Dr. Dortch has received research support from DOD.
María Eugenia Lopez, PhD Dr. López has nothing to disclose.
Charles Liu Mr. Liu has received personal compensation for serving as an employee of Alexion. Mr. Liu has stock in Alexion.
Nicholas Vigilante, III Mr. Vigilante has nothing to disclose.
Eileen Xu Miss Xu has nothing to disclose.
Abner Gershon, MD Dr. Gershon has nothing to disclose.
William Tackett Mr. Tackett has nothing to disclose.
Alexander Kuka, PhD Dr. Kuka has received personal compensation for serving as an employee of Click Therapeutics.
Jingyun Chen, PhD Dr. Chen has received personal compensation for serving as an employee of icometrix.
Faissal Stipho Mr. Stipho has nothing to disclose.
Saman Arfaie, Other Mr. Arfaie has nothing to disclose.
Sergio Luiz Junio, PhD Dr. Junio has nothing to disclose.
Kenyon W. Sprankle, III Mr. Sprankle has nothing to disclose.
Anam Khalid Shaikh Miss Shaikh has nothing to disclose.
Vanda McNiven, MD Dr. McNiven has nothing to disclose.
Jessica Cristine Da Si Garcia, Other Mrs. Garcia has nothing to disclose.
Christa Caggiano Miss Caggiano has nothing to disclose.
Noah Zaitlen, PhD The institution of Prof. Zaitlen has received research support from NIH.
Byoungchul Kim, MD Dr. Kim has nothing to disclose.
Fawaz Stipho, Other Mr. Stipho has nothing to disclose.
Heitor De Sousa Mota, MD Dr. Mota has nothing to disclose.
Carlos Alberto Campello, MD Dr. Campello has nothing to disclose.
Tina Rajnauth, MD Dr. Rajnauth has nothing to disclose.
Pascal Sati, PhD The institution of Dr. Sati has received research support from National Multiple Sclerosis Society. The institution of Dr. Sati has received research support from National Institutes of Health. Dr. Sati has received intellectual property interests from a discovery or technology relating to health care.
Kyoko Hiyoshi-Arai, PhD,RN Prof. Hiyoshi-Arai has received research support from Japanese government.
Isabela Reis Marques, Other Mrs. Reis Marques has nothing to disclose.
Ana Vitoria Cordeiro Rocha Miss Cordeiro Rocha has nothing to disclose.
Amanda Godoi Ms. Godoi has nothing to disclose.
Arun Aggarwal, FRACP Prof. Aggarwal has nothing to disclose.
Conor Reid Mr. Reid has nothing to disclose.
Jenna Stevenson, Other Miss Stevenson has nothing to disclose.
Cecile Tissot Mrs. Tissot has nothing to disclose.
Jade Marshall, Other Ms. Marshall has nothing to disclose.
Olya Besedina, RN Miss Besedina has received personal compensation for serving as an employee of Click Therapeutics Inc..
Vinod Rao, MD,PhD Dr. Rao has received research support from National Institute for Health. Dr. Rao has received research support from National Institute for Drug Abuse.
Stijn Servaes Dr. Servaes has nothing to disclose.
Yuhui Sha Ms. Sha has nothing to disclose.
Karl Josef Niño Jimenez Separa, MD Dr. Separa has nothing to disclose.
Daniel McDonald, Other Mr. McDonald has nothing to disclose.
Lili Ding, PhD Dr. Ding has nothing to disclose.
Gulandam Bagirova, Other Ms. BAGIROVA has nothing to disclose.
Daiana Elizabeth Dossi, MD Dr. Dossi has nothing to disclose.
Ilaria Bottale, Other Miss Bottale has nothing to disclose.
Arabinda Das, PhD Dr. DAS has nothing to disclose.
Amir Mina Mr. Mina has received intellectual property interests from a discovery or technology relating to health care.
Manisha Koneru, Other Ms. Koneru has nothing to disclose.
Aksha Memon, MBBS Dr. Memon has nothing to disclose.
Alison Roth, PhD Dr. Roth has nothing to disclose.
Libby Kosnik Infinger, MD Dr. Infinger has nothing to disclose.
Gabriel Marinheiro Marinheiro Dos Santos-Bezerra, Sr., Other Mr. Dos Santos-Bezerra has nothing to disclose.
Mira Chamoun, PhD Dr. Chamoun has nothing to disclose.
Gleb Bezgin Dr. Bezgin has nothing to disclose.
Sughajit Das Gupta Mr. GUPTA has nothing to disclose.
Shivani Daryani, PA Ms. Daryani has nothing to disclose.
Djemo Fade, Other Ms. Fade has nothing to disclose.
Brian Hilton Buck, MD Dr. Buck has nothing to disclose.
Shayna Pehel Ms. Pehel has nothing to disclose.
Yan Zhang Mr. Zhang has nothing to disclose.
Ugur Bilge, PhD Dr. Bilge has nothing to disclose.
Alon Bloom, MD Dr. Bloom has received personal compensation for serving as an employee of Neurocrine Biosciences. Dr. Bloom has stock in Neurocrine.
Saja Alzghoul Miss Alzghoul has nothing to disclose.
Jiyuan Hu, PhD Dr. Hu has nothing to disclose.
Jennifer Riojas, PhD Dr. Riojas has nothing to disclose.
Filipa Carvalho, Other Ms. Carvalho has nothing to disclose.
Ehaab Naim Saleem, Other Mr. Saleem has nothing to disclose.
Radhika Nair, MD Dr. Nair has nothing to disclose.
Fumihiro Watanabe, PhD Dr. Watanabe has nothing to disclose.
Iqra *Use 379943 Faiz, Masters student Ms. Faiz has nothing to disclose.
Madison Michelle Patrick Ms. Patrick has nothing to disclose.
Zaid Mohammad Khalefa Mr. Khalefa has nothing to disclose.
James Strathdee, MBBS Dr. Strathdee has nothing to disclose.
Mark Hester, PhD Dr. Hester has nothing to disclose.
Gloria Slattum, PhD Dr. Slattum has nothing to disclose.
Steffany Bennett, PhD The institution of Dr. Bennett has received research support from Prevail.
Refaat E. Gabr, PhD Dr. Gabr has received personal compensation for serving as an employee of Biogen. Dr. Gabr has stock in Biogen.
William Drew Mr. Drew has nothing to disclose.
Alexandra Berk, Other Ms. Berk has received personal compensation for serving as an employee of Invitae. Ms. Berk has stock in Invitae.
Diana Haggerty, PhD Dr. Haggerty has nothing to disclose.
Guangsong Han Mr. Han has nothing to disclose.
Ciara Hupp, MD Ms. Hupp has nothing to disclose.
Evan Bushnik Mr. Bushnik has nothing to disclose.
Mingyu Tang, MD Dr. Tang has nothing to disclose.
Raya Haley Kleinbart, Other Miss Kleinbart has nothing to disclose.
Kayhan Batmanghelich, PhD Dr. Batmanghelich has nothing to disclose.
Sydney Elizabeth Gilbert Miss Gilbert has nothing to disclose.
Kristie Kooken, Other Ms. Kooken has received personal compensation for serving as an employee of Revance Therapeutics. Ms. Kooken has stock in Revance Therapeutics .
Katherine Du Ms. Du has nothing to disclose.
Vinay Pedapati Mr. Pedapati has nothing to disclose.
Isabelle Charlotte Preddy Ms. Preddy has nothing to disclose.
Elizabeth Michelle Ferriman, RN Mrs. Ferriman has nothing to disclose.
Betsy Anne Kleiner, MD Dr. Kleiner has nothing to disclose.
Dinesh Selvarajah, PhD,MD Dr. Selvarajah has nothing to disclose.
Fiona Catherine Brock Mrs. Brock has received personal compensation for serving as an employee of UCB.
Federica Facente, Other Dr. Facente has nothing to disclose.
Michael Anthony Foster, MBBS The institution of Dr. Foster has received research support from Medical Research Council.
Tom Fitzgerald, Other Mr. Fitzgerald has nothing to disclose.
William Merhi, DO Dr. Merhi has nothing to disclose.
Elli Brimble, Other Ms. Brimble has received personal compensation for serving as an employee of Invitae. Ms. Brimble has stock in Invitae. Ms. Brimble has stock in Ciitizen.
Victoria Scott, RN Mrs. Scott has nothing to disclose.
Diane Hall Ms. Hall has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc..
Geoffrey Beek, Other Mr. Beek has received personal compensation for serving as an employee of invitae. Mr. Beek has stock in invitae.
Tanzina Islam, Other Ms. Islam has nothing to disclose.
Tanya Nelson Hall, RN Mrs. Nelson Hall has nothing to disclose.
Jaime Choate, RN Mrs. Choate has nothing to disclose.
Gregory Aiello, Other Mr. Aiello has nothing to disclose.
Jenna Bartley, PhD Dr. Bartley has nothing to disclose.
Elizabeth Klinepeter, PhD Dr. Klinepeter has nothing to disclose.
Herve Besson, PhD Dr. Besson has received personal compensation for serving as an employee of UCB.
Tomas Lucioni, MD Dr. Lucioni has nothing to disclose.
Karen Ripper, RN Ms. Ripper has received personal compensation for serving as an employee of the council on aging of Martin County Inc.
Quentin Spinat Mr. SPINAT has received personal compensation for serving as an employee of Therapanacea.
Marisa Marie Modjeski Miss Modjeski has nothing to disclose.
Allison Bradley, PhD Dr. Bradley has nothing to disclose.
Anna Sosa, Other Ms. Sosa has nothing to disclose.
Duane Berkompas, MD,NP Dr. Berkompas has received personal compensation in the range of $10,000-$49,999 for serving as a Proctor and consultant with Medtronic.
Brenda Trokthi, Other Miss Trokthi has nothing to disclose.
Jeremy Espino, MD Dr. Espino has stock in General Biodefense. Dr. Espino has stock in READE.ai. Dr. Espino has received intellectual property interests from a discovery or technology relating to health care.
Enrica Cavedo, PhD Dr. Cavedo has received personal compensation for serving as an employee of Qynapse. Dr. Cavedo has received personal compensation for serving as an employee of TheraPanacea.
Nagib Chalfoun, MD Dr. Chalfoun has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Chalfoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Atricure. Dr. Chalfoun has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Atricure.
Elizabeth Haddad, Other Miss Haddad has nothing to disclose.
Karen Gibbs, RN Ms. Gibbs has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Matthew Kolisnyk, Other Mr. Kolisnyk has nothing to disclose.
Michel Gauthier, Other Mr. Gauthier has nothing to disclose.
Elizabeth Margaret Sweeney, PhD Dr. Sweeney has nothing to disclose.
Scott Lindhorst, MD Dr. Lindhorst has nothing to disclose.
Vivian Mushahwar, PhD The institution of Prof. Mushahwar has received research support from University Hospital Foundation.
Mohammad Sadaghiani, MD Dr. Sadaghiani has nothing to disclose.
Ramin Eskandari, MD Dr. Eskandari has nothing to disclose.
Martin Ferguson-Pell, PhD Dr. Ferguson-Pell has stock in Click&Push Inc.. Dr. Ferguson-Pell has stock in Moshion Inc..
Olivier Teboul, PhD Dr. Teboul has nothing to disclose.
Amelie Lothe, PhD Dr. Lothe has received personal compensation for serving as an employee of UCB. Dr. Lothe has received personal compensation for serving as an employee of Zogenix International Limited. Dr. Lothe has stock in Zogenix .
Baris Kanber, PhD Dr. Kanber has nothing to disclose.
Jeremy Hall, MD, PhD Prof. Hall has stock in meomics. The institution of Prof. Hall has received research support from takeda.
Takahiro Amano Prof. Amano has nothing to disclose.
Azita Khorsandi, MD Dr. Khorsandi has nothing to disclose.
Sergiu Pasca, MD Prof. Pasca has received intellectual property interests from a discovery or technology relating to health care.
Megan Merrifield, Other Ms. Merrifield has received personal compensation for serving as an employee of The Council on Aging of Martin County - The Kane Center.
Lakshmi Chauhan, MD The institution of Dr. Chauhan has received research support from NIH. The institution of an immediate family member of Dr. Chauhan has received research support from University of Colorado.
Ella Perrault Miss Perrault has nothing to disclose.
Srikirti Kodali, MBBS Dr. Kodali has nothing to disclose.
Jenny Qian Ms. Qian has received personal compensation for serving as an employee of Xenon Pharmaceuticals.
Maya Rawal, Other Ms. Rawal has nothing to disclose.
John David Beckham, MD The institution of Dr. Beckham has received research support from Roche Diagnostics.
Sam Hsiao, PhD Dr. Hsiao has received personal compensation for serving as an employee of Takeda Pharmaceutical Company. Dr. Hsiao has stock in Takeda Pharmaceutical Company.
Maariyah Kharal Miss Kharal has nothing to disclose.
Tejas Patel Dr. Patel has nothing to disclose.
Reza Moulavi Moulavi Ardakani Mr. Moulavi Ardakani has nothing to disclose.
Vincent Lepetit Dr. Lepetit has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Therapanacea.
Zhaonan Sun, PhD Dr. Sun has received personal compensation for serving as an employee of Biogen. Dr. Sun has stock in Biogen.
Androu Abdalmalak, PhD Dr. Abdalmalak has nothing to disclose.
Basil Memon, Other Mr. Memon has nothing to disclose.
Francis Jordan Chavez Milla, MD Dr. Milla has nothing to disclose.
Danae Clark Dowd, NP Mrs. Clark Dowd has nothing to disclose.
Cindy Yuen, DO Dr. Yuen has nothing to disclose.
Musa Issa Dahu, MD Dr. Dahu has nothing to disclose.
Cassandra Snipes, PhD Dr. Snipes has received personal compensation for serving as an employee of Click Therapeutics. Dr. Snipes has received publishing royalties from a publication relating to health care.
William Scott Harmsen, Other Mr. Harmsen has nothing to disclose.
Tarah Moelker, RN Mrs. Moelker has nothing to disclose.
Freddie Hildreth, II, Other Mr. Hildreth has nothing to disclose.
Geoffrey Chow, MBBS Dr. Chow has nothing to disclose.
Ivy So Yeon Kim, Other Mrs. Kim has received personal compensation for serving as an employee of Boston Medical Center.
Hiba Afroze Saleem Miss A Saleem has nothing to disclose.
Atique U. Ahmed, PhD The institution of Dr. Ahmed has received research support from NIH.
Brian Saway, MD Dr. Saway has nothing to disclose.
Higashino Sadanori, PhD Prof. Sadanori has nothing to disclose.
Cristina Villa, Other Miss Villa has nothing to disclose.
Abdulmalik Saleem, Other Mr. Saleem has nothing to disclose.
Jay Knight, RN,Other Dr. Knight has nothing to disclose.
Andre Gauri, MD Dr. Gauri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medtronic . Dr. Gauri has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Atricure .
Arenn Faye Carlos, MD Dr. Carlos has nothing to disclose.
Gail J. Demmler Harrison Dr. Demmler Harrison has received personal compensation in the range of $0-$499 for serving as a Consultant for Moderna. Dr. Demmler Harrison has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Moderna. Dr. Demmler Harrison has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for WebMD Medscape. The institution of Dr. Demmler Harrison has received research support from Merck. The institution of Dr. Demmler Harrison has received research support from Microgen. Dr. Demmler Harrison has received publishing royalties from a publication relating to health care. Dr. Demmler Harrison has received publishing royalties from a publication relating to health care.
Shaji Kunnathu Kumar, MD Prof. KUMAR has nothing to disclose.
Shivam Patel Mr. Patel has nothing to disclose.
Brian Dewar No disclosure on file
Christopher Kenney Christopher Kenney has received personal compensation for serving as an employee of Xenon Pharmaceuticals.
Jiangxia Zhang No disclosure on file
Sunil J. Patel No disclosure on file
Abhay K. Varma No disclosure on file
Annie Fukushima No disclosure on file
Marion Le Marechal No disclosure on file
Elise Longnecker No disclosure on file
Kacey Madsen No disclosure on file
Megan McKay No disclosure on file
Katherine Meuer No disclosure on file
Marcio Souza Dr. Souza has received personal compensation for serving as an employee of Praxis Precision Medicines. Dr. Souza has stock in Praxis Precision Medicines.
Mallory Alonso, PharmD Dr. Alonso has received personal compensation for serving as an employee of UCB, Inc.. Dr. Alonso has stock in UCB, Inc..